Knowledge

G-quadruplex

Source đź“ť

991:; this allows the small-molecule ligands to stack on the planar terminal tetrads within the G-quadruplex regions. A disadvantage of using small-molecule ligands as a therapeutic technique is that specificity is difficult to manage due to the variability of G-quadruplexes in their primary sequences, orientation, thermodynamic stability, and nucleic acid strand stoichiometry. As of now, no single small-molecule ligand has been able to be perfectly specific for a single G-quadruplex sequence. However, a cationic porphyrin known as TMPyP4 is able to bind to the C9orf72 GGGGCC repeat region, which causes the G-quadruplex repeat region to unfold and lose its interactions with proteins causing it to lose its functionality. Small-molecule ligands, composed primarily of lead, can target GGGGCC repeat regions as well and ultimately decreased both repeat-associated non-ATG translation and RNA foci in neuron cells derived from patients with 413:, has also been identified as a key G-quadruplex resolvase. In 2009, a metastasis suppressor protein NM23H2 (also known as NME2) was found to directly interact with G-quadruplex in the promoter of the c-myc gene, and transcriptionally regulate c-myc. More recently, NM23H2 was reported to interact with G-quadruplex in the promoter of the human telomerase (hTERT) gene and regulate hTERT expression In 2019, the telomere-binding-factor-2 (TRF2 or TERF2) was shown to bind to thousands of non-telomeric G-quadruplexes in the human genome by TRF2 ChIP-seq. There are many studies that implicate quadruplexes in both positive and negative transcriptional regulation, including epigenetic regulation of genes like hTERT. Function of G-quadruplexes have also been reported in allowing programmed recombination of immunologlobin heavy genes and the pilin 292:. Analysis of human, chimpanzee, mouse and rat genomes showed enormous number of potential G-quadruplex (pG4)-forming sequences in non-telomeric regions. A large number of the non-telomeric G-quadruplexes were found within gene promoters, and were conserved across the species. Similarly, large number of G-quadruplexes were found in the E. coli and hundreds of other microbial genomes. Here also, like vertebrates G-quadruplexes were enriched within gene promoters. In addition, there was found more than one-billion-year conserved G-quadruplex locus in plants and algae, in gene encoding large subunit of RNA polymerase II. Although these studies predicted G-quadruplex-mediated gene regulation, it is unlikely that all pG4s would form in vivo. The 162:. However, as currently used in molecular biology, the term G4 can mean G-quadruplexes of any molecularity. Longer sequences, which contain two contiguous runs of three or more guanine bases, where the guanine regions are separated by one or more bases, only require two such sequences to provide enough guanine bases to form a quadruplex. These structures, formed from two separate G-rich strands, are termed bimolecular quadruplexes. Finally, sequences which contain four distinct runs of guanine bases can form stable quadruplex structures by themselves, and a quadruplex formed entirely from a single strand is called an intramolecular quadruplex. 130:, these structures hold a biologically relevant role through interactions with the promoter regions of oncogenes and the telomeric regions of DNA strands. Current research consists of identifying the biological function of these G-Quadruplex structures for specific oncogenes and discovering effective therapeutic treatments for cancer based on interactions with G-quadruplexes. Early evidence for the formation of G-quadruplexes in vivo in cells was established by isolating them from cells, and later by the observation that specific DNA helicases could be identified where small molecules specific for these DNA structures accumulated in cells. 798:
these signals at 262 and 295 nm, respectively. To verify G-quadruplex formation, one should also perform the CD experiments under non-G-quadruplex stabilizing (Li+) and G-quadruplex stabilizing conditions (such as K+ or with G-quadruplex ligands), and scan toward the far-UV region (180–230 nm). Likewise, the thermostability of the G-quadruplex structure can be identified by observing the UV signal at 295 nm. Upon G-quadruplex melting, the UV absorbance at 295 nm decreases, leading to a hypochromic shift that is a distinctive feature of G-quadruplex structure. Another approach for detection of G-quadruplexes includes
547:
behind the loading of these TFs, where APE1 dissociates from the G-quadruplex structures. When a study downregulated the presence of APE1 and AcAPE1 in the cell, the formation of G-quadruplex structures was inhibited, which proves the importance of APE1 for the formation of these structures. However, not all G-quadruplex structures require APE1 for formation, in fact some of them formed greater G-quadruplex structures in its absence. Therefore, we can conclude that APE1 has two important roles in genome regulation- Stabilizing the formation of g-quadruplex structures and loading the transcriptional factors onto the AP site
453:(BER). Base excision repair processes in cells have been proved to be reduced with aging as its components in the mitochondria begin to decline, which can lead to the formation of many diseases such as Alzheimer's disease (AD). These G-quadruplex structures are said to be formed in the promoter regions of DNA through superhelicity, which favors the unwinding of the double helical structure of DNA and in turn loops the strands to form G-quadruplex structures in guanine rich regions. The BER pathway is signalled when it indicates an oxidative DNA base damage, where structures like, 166:
intramolecular quadruplexes, this means that any loop regions present must be of the propeller type, positioned to the sides of the quadruplex. If one or more of the runs of guanine bases has a 5’-3’ direction opposite to the other runs of guanine bases, the quadruplex is said to have adopted an antiparallel topology. The loops joining runs of guanine bases in intramolecular antiparallel quadruplexes are either diagonal, joining two diagonally opposite runs of guanine bases, or lateral (edgewise) type loops, joining two adjacent runs of guanine base pairs.
423:. The roles of quadruplex structure in translation control are not as well explored. The direct visualization of G-quadruplex structures in human cells as well as the co-crystal structure of an RNA helicase bound to a G-quadruplex have provided important confirmations of their relevance to cell biology. The potential positive and negative roles of quadruplexes in telomere replication and function remains controversial. T-loops and G-quadruplexes are described as the two tertiary DNA structures that protect telomere ends and regulate telomere length. 763:. Although the rule effectively identifies sites of G-quadruplex formation, it also identifies a subset of the imperfect homopurine mirror repeats capable of triplex formation and C-strand i-motif formation. Moreover, these sequences also have the capacity to form slipped and foldback structures that are implicit intermediates in the formation of both quadruplex and triplex DNA structures. In one study, it was found that the observed number per base pair (i.e. the frequency) of these motifs has increased rapidly in the 542:
G-quadruplex structures in that region. This promotes formation of G-quadruplex structures by the folding of the stand. This looping process brings four bases in close proximity that will be held together by Hoogsteen base pairing. After this stage the APE1 gets acetylated by multiple lysine residues on the chromatin, forming acetylated APE1 (AcAPE1). AcAPE1 is very crucial to the BER pathway as it acts as a transcriptional coactivator or corepressor, functioning to load
20: 654:
regions to inhibit the production of both the c-Myc protein product and the human telomerase reverse transcriptase (hTERT). This main pathway of targeting this region results in the lack of telomerase elongation, leading to arrested cell development. Further research remains necessary for the discovery of a single gene target to minimize unwanted reactivity with more efficient antitumor activity.
38:. They are helical in shape and contain guanine tetrads that can form from one, two or four strands. The unimolecular forms often occur naturally near the ends of the chromosomes, better known as the telomeric regions, and in transcriptional regulatory regions of multiple genes, both in microbes and across vertebrates including oncogenes in humans. Four guanine bases can associate through 614:
through the abundant guanine sequence in the promoter region of this specific pathway. The cyclin-dependent cell cycle checkpoint kinase inhibitor-1 CDKN1A (also known as p21) gene harbours promoter G-quadruplex. Interaction of this G-quadruplex with TRF2 (also known as TERF2) resulted in epigenetic regulation of p21, which was tested using the G-quadruplex-binding ligand 360A.
621:. Through recent research into this specific gene pathway, the polypurine and polypyrimidine region allows for the transcription of this specific gene and the formation of an intramolecular G-quadruplex structure. However, more research is necessary to determine whether the formation of G-quadruplex regulates the expression of this gene in a positive or negative manner. 89:. G-quadruplex structures can be computationally predicted from DNA or RNA sequence motifs, but their actual structures can be quite varied within and between the motifs, which can number over 100,000 per genome. Their activities in basic genetic processes are an active area of research in telomere, gene regulation, and functional genomics research. 637:
the promoter region of PDGF-A has exhibited the ability to form intramolecular parallel G-quadruplex structures and remains suggested to play a role in transcriptional regulation of PDGF-A. However, research has also identified the presence of G-quadruplex structures within this region due to the interaction of TMPyP4 with this promoter sequence.
568:.  However, in cancer cells that have mutated helicase these complexes cannot be unwound and leads to potential damage of the cell. This causes replication of damaged and cancerous cells. For therapeutic advances, stabilizing the G-quadruplexes of cancerous cells can inhibit cell growth and replication leading to the 714:. Furthermore, the hydrogen bonds of ligands with smaller side chains are shorter and therefore stronger. Ligands with mobile side chains, ones that are able to rotate around its center chromophore, associate more strongly to G-quadruplexes because conformation of the G4 loops and the ligand side chains can align. 653:
Ligand design and development remains an important field of research into therapeutic reagents due to the abundance of G-quadruplexes and their multiple conformational differences. One type of ligand involving a Quindoline derivative, SYUIQ-05, utilizes the stabilization of G-quadruplexes in promoter
636:
Another oncogene pathway involving PDGF-A, platelet-derived growth factor, involves the process of wound healing and function as mitogenic growth factors for cells. High levels of expression of PDGF have been associated with increased cell growth and cancer. The presence of a guanine-rich sequence in
528:
AP endonuclease 1 (APE1) is an enzyme responsible for the promotion and the formation of G-quadruplex structures. APE1 is mainly in charge of repairing damage caused to AP sites through the BER pathway. APE1 is considered to be very crucial as AP site damage is known to be the most recurring type of
541:
does so by cleaving the oxidized base and thus creating an AP site, primarily through the process of negative superhelicity. This AP site then signals cells to engage APE1 binding, which binds to the open duplex region. The binding of APE1 then plays an important role by stabilizing the formation of
998:
Metal complexes have a number of features that make them particularly suitable as G4 DNA binders and therefore as potential drugs. While the metal plays largely a structural role in most G4 binders, there are also examples where it interacts directly with G4s by electrostatic interactions or direct
546:
into the site of damage allowing it to regulate the gene expression. AcAPE1 is also very important since it allows APE1 to bind for longer periods of time by delay of its dissociation from the sequence, allowing the repair process to be more efficient. Deacetylation of AcAPE1 is the driving force
448:
and ARP, have indicated that AP site damage occurrence is nonrandom. AP site damage was also more prevalent in certain regions of the genome that contain specific active promoter and enhancer markers, some of which were linked to regions responsible for lung adenocarcinoma and colon cancer. AP site
5572:
Rutherford NJ, Heckman MG, Dejesus-Hernandez M, Baker MC, Soto-Ortolaza AI, Rayaprolu S, Stewart H, Finger E, Volkening K, Seeley WW, Hatanpaa KJ, Lomen-Hoerth C, Kertesz A, Bigio EH, Lippa C, Knopman DS, Kretzschmar HA, Neumann M, Caselli RJ, White CL, Mackenzie IR, Petersen RC, Strong MJ, Miller
797:
The topology of the G-quadruplex structure can be determined by monitoring the positive or negative circular dichroism (CD) signals at specific wavelengths. Parallel G-quadruplexes have negative and positive CD signals at 240 and 262 nm, respectively, whereas antiparallel G-quadruplexes place
613:
of the VEGF gene. Through recent research on the role of G-quadruplex function in vivo, the stabilization of G-quadruplex structures was shown to regulate VEGF gene transcription, with inhibition of transcription factors in this pathway. The intramolecular G-quadruplex structures are formed mostly
952:
are common strategies used to target neurological diseases linked to G-quadruplex expansion repeats. Therefore, these techniques are especially advantageous for targeting neurological diseases that have a gain-of-function mechanism, which is when the altered gene product has a new function or new
788:
Biochemical techniques were employed to interrogate G-quadruplex formation in a longer sequence context. In the DNA polymerase stop assay, the formation of a G-quadruplex in a DNA template can act as a roadblock and cause polymerase stalling, which halts the primer extension. The dimethyl sulfate
649:
which makes them effective anticancer agents. However, TMPyP4 has been limited for used due to its non-selectivity toward cancer cell telomeres and normal double stranded DNA (dsDNA). To address this issue analog of TMPyP4, it was synthesized known as 5Me which targets only G quadruplex DNA which
632:
which has been abundant in certain types of cancer. The guanine rich sequence in the promoter region for this pathway exudes a necessity for baseline transcription of this receptor tyrosine kinase. In certain types of cancers, the RET protein has shown increased expression levels. The research on
592:
and VEGF, showing the importance of this secondary structure in cancer growth and development. While the formation of G-quadruplex structure vary to some extent for the different promoter regions of oncogenes, the consistent stabilization of these structures have been found in cancer development.
125:
function of G-quadruplexes surged after large scale genome-wide analysis showed the prevalence of potential G-quadruplex (pG4)-forming sequences within gene promoters of human, chimpanzee, mouse, and rat - presented in the First International G-quadruplex Meeting held in April 2007 in Louisville,
963:
is the process by which synthesized strands of nucleic acids are used to bind directly and specifically to the mRNA produced by a certain gene, which will inactivate it. Antisense oligonucleotides (ASOs) are commonly used to target C9orf72 RNA of the G-quadruplex GGGGCC expansion repeat region,
507:
Furthermore, the concentration of 8-oxo-dG is a known biomarker of oxidative stress within a cell, and excessive amount of oxidative stress has been linked to carcinogenesis and other diseases. When produced, 8-oxo-dG, has the ability to inactivate OGG1, thus preventing the repair of DNA damage
6167:
Lagier-Tourenne C, Baughn M, Rigo F, Sun S, Liu P, Li HR, Jiang J, Watt AT, Chun S, Katz M, Qiu J, Sun Y, Ling SC, Zhu Q, Polymenidou M, Drenner K, Artates JW, McAlonis-Downes M, Markmiller S, Hutt KR, Pizzo DP, Cady J, Harms MB, Baloh RH, Vandenberg SR, Yeo GW, Fu XD, Bennett CF, Cleveland DW,
608:
Another gene pathway deals with the VEGF gene, Vascular Endothelial Growth Factor, which remains involved in the process of angiogenesis or the formation of new blood vessels. The formation of an intramolecular G-quadruplex structure has been shown through studies on the polypurine tract of the
624:
The c-kit oncogene deals with a pathway that encodes an RTK, which was shown to have elevated expression levels in certain types of cancer. The rich guanine sequence of this promoter region has shown the ability to form a variety of quadruplexes. Current research on this pathway is focusing on
604:
Regulation of c-myc through Human telomerase reverse transcriptase (hTERT) is also directly regulated through promoter G-quadruplex by interaction with the transcription factor NM23H2 where epigenetic modifications were dependent on NM23H2-G-quadruplex association. Recently, hTERT epigenetic
165:
Depending on how the individual runs of guanine bases are arranged in a bimolecular or intramolecular quadruplex, a quadruplex can adopt one of a number of topologies with varying loop configurations. If all strands of DNA proceed in the same direction, the quadruplex is termed parallel. For
226:
adds TTAGGG repeats at the 3’ end of DNA strands. At these 3’ end protrusions, the G-rich overhang can form secondary structures such as G-quadruplexes if the overhang is longer than four TTAGGG repeats. The presence of these structures prevent telomere elongation by the telomerase complex.
971:
that mimic the G-quadruplex structure and compete with the endogenous G-quadruplexes for binding to transcription factors. These decoys are typically composed of a G-rich sequence that can form a stable G-quadruplex structure and a short linker region that can be modified to optimize their
964:
which has lowered the toxicity in cellular models of C9orf72. ASOs have previously been used to restore normal phenotypes in other neurological diseases that have gain-of-function mechanisms, the only difference is that it was used in the absence of G-quadruplex expansion repeat regions.
494:
to bind and remove the oxidative damage with the help of APE1, resulting in an AP site. Moreover, an AP site is a location in DNA that has neither a purine or a pyrimidine base due to DNA damage, they are the most prevalent type of endogenous DNA damage in cells. AP sites can be generated
157:
The length of the nucleic acid sequences involved in tetrad formation determines how the quadruplex folds. Short sequences, consisting of only a single contiguous run of three or more guanine bases, require four individual strands to form a quadruplex. Such a quadruplex is described as
435:
A new technique to map AP sites has been developed known as AP-seq which utilizes a biotin-labeled aldehyde-reactive probe (ARP) to tag certain regions of the genome where AP site damage occurrence has been significant. Another genome-wide mapping sequencing method known as
822:
G-quadruplexes have been implicated in neurological disorders through two main mechanisms. The first is through expansions of G-repeats within genes that lead to the formation of G-quadruplex structures that directly cause disease, as is the case with the C9orf72 gene and
596:
One particular gene region, the c-myc pathway, plays an integral role in the regulation of a protein product, c-Myc. With this product, the c-Myc protein functions in the processes of apoptosis and cell growth or development and as a transcriptional control on human
709:
When designing ligands to be bound to G-quadruplexes, the ligands have a higher affinity for parallel folded G-quadruplexes.  It has been found that ligands with smaller side chains bind better to the quadruplex because smaller ligands have more concentrated
137:
3D Structure of the intramolecular human telomeric G-quadruplex in potassium solution. The backbone is represented by a tube. The center of this structure contains three layers of G-tetrads. The hydrogen bonds in these layers are represented by blue dashed lines.
789:(DMS) followed by the piperidine cleavage assay is based on the fact that the formation of a G-quadruplex will prohibit the N7 guanine methylation caused by DMS, leading to a protection pattern observed at the DNA G-quadruplex region after piperidine cleavage. 771:
More recently, advanced web-based toolboxes for identifying G-quadruplex forming sequences were developed, including user-friendly and open access version of G4Hunter based on sliding window approach or G4RNA Screener based on machine learning algorithm.
217:
function to provide this signaling. Telomeres, rich in guanine and with a propensity to form g-quadruplexes, are located at the terminal ends of chromosomes and help maintain genome integrity by protecting these vulnerable terminal ends from instability.
529:
endogenous damage to DNA. The oxidation of certain purine bases, like guanine, forms oxidized nucleotides that impairs DNA function by mismatching nucleotides in the sequences. This is more common in PQS sequences which form oxidized structures, such as
6117:
Donnelly CJ, Zhang PW, Pham JT, Haeusler AR, Heusler AR, Mistry NA, Vidensky S, Daley EL, Poth EM, Hoover B, Fines DM, Maragakis N, Tienari PJ, Petrucelli L, Traynor BJ, Wang J, Rigo F, Bennett CF, Blackshaw S, Sattler R, Rothstein JD (October 2013).
722:
Identifying and predicting sequences which have the capacity to form quadruplexes is an important tool in further understanding their role. Generally, a simple pattern match is used for searching for possible intrastrand quadruplex forming sequences:
4620:
Chilakamarthi U, Koteshwar D, Jinka S, Vamsi Krishna N, Sridharan K, Nagesh N, Giribabu L (November 2018). "Novel Amphiphilic G-Quadruplex Binding Synthetic Derivative of TMPyP4 and Its Effect on Cancer Cell Proliferation and Apoptosis Induction".
6491:
Cogoi S, Paramasivam M, Filichev V, GĂ©ci I, Pedersen EB, Xodo LE (January 2009). "Identification of a new G-quadruplex motif in the KRAS promoter and design of pyrene-modified G4-decoys with antiproliferative activity in pancreatic cancer cells".
1372:
Verma A, Halder K, Halder R, Yadav VK, Rawal P, Thakur RK, Mohd F, Sharma A, Chowdhury S (2008). "Genome-wide Computational and Expression Analyses Reveal G-quadruplex DNA Motifs as Conserved Cis-Regulatory Elements in Human and Related Species".
7067:
Hou X, Guo W, Xia F, Nie FQ, Dong H, Tian Y, Wen L, Wang L, Cao L, Yang Y, Xue J, Song Y, Wang Y, Liu D, Jiang L (June 2009). "A biomimetic potassium responsive nanochannel: G-quadruplex DNA conformational switching in a synthetic nanopore".
221:
These telomeric regions are characterized by long regions of double-stranded CCCTAA:TTAGGG repeats. The repeats end with a 3’ protrusion of between 10 and 50 single-stranded TTAGGG repeats. The heterodimeric complex ribonucleoprotein enzyme
694:
holding it together.  When bound, MM41's central chromophore is situated on top of the 3’ terminal G-quartet and the side chains of the ligand associate to the loops of the quadruplex. The quartet and the chromophore are bound with a
4305:
Ou TM, Lin J, Lu YJ, Hou JQ, Tan JH, Chen SH, Li Z, Li YP, Li D, Gu LQ, Huang ZS (August 2011). "Inhibition of cell proliferation by quindoline derivative (SYUIQ-05) through its preferential interaction with c-myc promoter G-quadruplex".
508:
caused by the oxidation of guanine. The possible inactivation allows for un-repaired DNA damages to gather in non-replicating cells, like muscle, and can cause aging as well. Moreover, oxidative DNA damage like 8-oxo-dG contributes to
212:
Because repair enzymes would naturally recognize ends of linear chromosomes as damaged DNA and would process them as such to harmful effect for the cell, clear signaling and tight regulation is needed at the ends of linear chromosomes.
6227:
Sareen D, O'Rourke JG, Meera P, Muhammad AK, Grant S, Simpkinson M, Bell S, Carmona S, Ornelas L, Sahabian A, Gendron T, Petrucelli L, Baughn M, Ravits J, Harms MB, Rigo F, Bennett CF, Otis TS, Svendsen CN, Baloh RH (October 2013).
995:(ALS). This provides evidence that small-molecule ligands are an effective and efficient process to target GGGGCC regions, and that specificity for small-molecule ligand binding is a feasible goal for the scientific community. 4428:
Hussain T, Saha D, Purohit G, Mukherjee AK, Sharma S, Sengupta S, Dhapola P, Maji B, Vedagopuram S, Horikoshi NT, Horikoshi N, Pandita RK, Bhattacharya S, Bajaj A, Riou JF, Pandita TK, Chowdhury S (September 2017).
495:
spontaneously or after the cleavage of modified bases, like 8-OH-Gua. The generation of an AP site enables the melting of the duplex DNA to unmask the PQS, adopting a G-quadruplex fold. With the use of genome-wide
1825:
Rodriguez, Raphaël; Miller, Kyle M; Forment, Josep V; Bradshaw, Charles R; Nikan, Mehran; Britton, Sébastien; Oelschlaegel, Tobias; Xhemalce, Blerta; Balasubramanian, Shankar; Jackson, Stephen P (5 February 2012).
684:
The binding of ligands to G-quadruplexes is vital for anti-cancer pursuits because G-quadruplexes are found typically at translocation hot spots.  MM41, a ligand that binds selectively for a quadruplex on the
4486:
De Armond R, Wood S, Sun D, Hurley LH, Ebbinghaus SW (December 2005). "Evidence for the presence of a guanine quadruplex forming region within a polypurine tract of the hypoxia inducible factor 1alpha promoter".
689:
promoter, is shaped with a central core and 4 side chains branching sterically out.  The shape of the ligand is vital because it closely matches the quadruplex which has stacked quartets and the loops of
5622:
Beck J, Poulter M, Hensman D, Rohrer JD, Mahoney CJ, Adamson G, Campbell T, Uphill J, Borg A, Fratta P, Orrell RW, Malaspina A, Rowe J, Brown J, Hodges J, Sidle K, Polke JM, Houlden H, Schott JM, Fox NC,
4381:"Facilitation of a structural transition in the polypurine/polypyrimidine tract within the proximal promoter region of the human VEGF gene by the presence of potassium and G-quadruplex-interactive agents" 469:
Guanine (G) bases in G-quadruplex have the lowest redox potential causing it to be more susceptible to the formation of 8-oxoguanine (8-oxoG), an endogenous oxidized DNA base damage in the genome. Due to
126:
Kentucky. In 2006, the prevalence of G-quadruplexes within gene promoters of several bacterial genomes was reported predicting G-quadruplex-mediated gene regulation. With the abundance of G-quadruplexes
767:
for which complete genomic sequences are available. This suggests that the sequences may be under positive selection enabled by the evolution of systems capable of suppressing non-B structure formation.
482:
within a cell. When DNA undergoes oxidative damage, a possible structural change in guanine, after ionizing radiation, gives rise to an enol form, 8-OH-Gua. This oxidative product is formed through a
431:
Many of the genome regulatory processes have been linked to the formation of G-quadruplex structures, attributable to the huge role it plays in DNA repair of apurinic/apyrimidinic sites also known as
699:
while the side chains and loops are not bound but are in close proximity. What makes this binding strong is the fluidity in the position of the loops to better associate with the ligand side chains.
967:
The G-quadruplex decoy strategy is another promising approach for targeting cancer cells by exploiting the unique structural features of the G-quadruplex. The strategy involves designing synthetic
254:) consists of many repeats of the sequenced (TTAGGG), and the quadruplexes formed by this structure can be in bead-like structures of 5 nm to 8 nm in size and have been well studied by 588:
promoter regions. The structures most present in the promoter regions of these oncogenes tend to be parallel-stranded G-quadruplex DNA structures. Some of these oncogenes include c-KIT, PDGF-A,
3647:"The importance of negative superhelicity in inducing the formation of G-quadruplex and i-motif structures in the c-Myc promoter: implications for drug targeting and control of gene expression" 169:
In quadruplexes formed from double-stranded DNA, possible interstrand topologies have also been discussed . Interstrand quadruplexes contain guanines that originate from both strands of dsDNA.
564:
cells, especially in telomeres, 5` untranslated strands, and translocation hot spots. G-quadruplexes can inhibit normal cell function, and in healthy cells, are easily and readily unwound by
670:, can bind to the G-quadruplex. These ligands can be naturally occurring or synthetic. This has become an increasingly large field of research in genetics, biochemistry, and pharmacology. 512:
through the modulation of gene expression, or the induction of mutations. On the condition that 8-oxo-dG is repaired by BER, parts of the repair protein is left behind which can lead to
987:. These can be used to target G-quadruplex regions that cause neurological disorders. Approximately 1,000 various G-quadruplex ligands exist in which they are able to interact via their 4664:
Ohnmacht SA, Marchetti C, Gunaratnam M, Besser RJ, Haider SM, Di Vita G, Lowe HL, Mellinas-Gomez M, Diocou S, Robson M, Ĺ poner J, Islam B, Pedley RB, Hartley JA, Neidle S (June 2015).
101:
association became apparent in the early 1960s, through the identification of gel-like substances associated with guanines. More specifically, this research detailed the four-stranded
7239: 134: 1725:
Henderson E, Hardin CC, Walk SK, Tinoco I, Blackburn EH (December 1987). "Telomeric DNA oligonucleotides form novel intramolecular structures containing guanine-guanine base pairs".
7122:
Rowland GB, Barnett K, Dupont JI, Akurathi G, Le VH, Lewis EA (December 2013). "The effect of pyridyl substituents on the thermodynamics of porphyrin binding to G-quadruplex DNA".
181:, many guanine-rich sequences that had the potential to form quadruplexes were discovered. Depending on cell type and cell cycle, mediating factors such as DNA-binding proteins on 617:
Hypoxia inducible factor 1É‘, HIF-1É‘, remains involved in cancer signaling through its binding to Hypoxia Response Element, HRE, in the presence of hypoxia to begin the process of
6442:
Gagnon KT, Pendergraff HM, Deleavey GF, Swayze EE, Potier P, Randolph J, Roesch EB, Chattopadhyaya J, Damha MJ, Bennett CF, Montaillier C, Lemaitre M, Corey DR (November 2010).
6529:"MAZ-binding G4-decoy with locked nucleic acid and twisted intercalating nucleic acid modifications suppresses KRAS in pancreatic cancer cells and delays tumor growth in mice" 912:
Fragile X mental retardation protein (FMRP) is a widely expressed protein coded by the FMR1 gene that binds to G-quadruplex secondary structures in neurons and is involved in
401:
switching. As cells have evolved mechanisms for resolving (i.e., unwinding) quadruplexes that form. Quadruplex formation may be potentially damaging for a cell; the helicases
49:
The placement and bonding to form G-quadruplexes is not random and serve very unusual functional purposes. The quadruplex structure is further stabilized by the presence of a
499:
analyses, cell-based assays, and in vitro biochemical analyses, a connection has been made between oxidized DNA base-derived AP sites, and the formation of the G-quadruplex.
197:
indicate that the antiparallel g-quadruplex is stabilized by molecular crowding. This effect seems to be mediated by alteration of the hydration of the DNA and its effect on
780:
A number of experimental methods have been developed to identify G-quadruplexes. These methods can be broadly defined into two classes: biophysical and biochemical methods.
1126:
Largy E, Mergny J, Gabelica V (2016). "Chapter 7. Role of Alkali Metal Ions in G-Quadruplex Nucleic Acid Structure and Stability". In Astrid S, Helmut S, Roland KO (eds.).
6395:"Potent and selective antisense oligonucleotides targeting single-nucleotide polymorphisms in the Huntington disease gene / allele-specific silencing of mutant huntingtin" 158:
tetramolecular, reflecting the requirement of four separate strands. The term G4 DNA was originally reserved for these tetramolecular structures that might play a role in
6770:
Ren J, Wang J, Han L, Wang E, Wang J (October 2011). "Kinetically grafting G-quadruplexes onto DNA nanostructures for structure and function encoding via a DNA machine".
6648:"TMPyP4 porphyrin distorts RNA G-quadruplex structures of the disease-associated r(GGGGCC)n repeat of the C9orf72 gene and blocks interaction of RNA-binding proteins" 2349:
Paeschke K, Simonsson T, Postberg J, Rhodes D, Lipps HJ (October 2005). "Telomere end-binding proteins control the formation of G-quadruplex DNA structures in vivo".
706: The way in which TMPyP4 binds to G4's is similar to MM41, with the ring stacking onto the external G-quartet and side chains associating to the loops of G4's. 6033:
Sutcliffe JS, Nelson DL, Zhang F, Pieretti M, Caskey CT, Saxe D, Warren ST (September 1992). "DNA methylation represses FMR-1 transcription in fragile X syndrome".
5225:
Sun D, Hurley LH (2009-10-23). "Biochemical Techniques for the Characterization of G-Quadruplex Structures: EMSA, DMS Footprinting, and DNA Polymerase Stop Assay".
625:
discovering the biological function of this specific quadruplex formation on the c-kit pathway, while this quadruplex sequence has been noticed in various species.
4573:"Characterization of the G-quadruplexes in the duplex nuclease hypersensitive element of the PDGF-A promoter and modulation of PDGF-A promoter activity by TMPyP4" 645:
Telomeres are generally made up of G-quadruplexes and remain important targets for therapeutic research and discoveries. These complexes have a high affinity for
807: 449:
damage was found to be predominant in PQS regions of the genome, where formation of G-quadruplex structures is regulated and promoted by the DNA repair process,
4952:
Mirkin SM, Lyamichev VI, Drushlyak KN, Dobrynin VN, Filippov SA, Frank-Kamenetskii MD (1987). "DNA H form requires a homopurine-homopyrimidine mirror repeat".
803: 520:
gene of humans, it was determine that if 8-oxo-dG was left unchecked and not repaired by BER, it can lead to frequent mutations and eventually carcinogenesis.
46:(G-tetrad or G-quartet), and two or more guanine tetrads (from G-tracts, continuous runs of guanine) can stack on top of each other to form a G-quadruplex. 5629:"Large C9orf72 hexanucleotide repeat expansions are seen in multiple neurodegenerative syndromes and are more frequent than expected in the UK population" 5276:
Paramasivan S, Rujan I, Bolton PH (December 2007). "Circular dichroism of quadruplex DNAs: applications to structure, cation effects and ligand binding".
109:
regions of DNA in the 1980s. The importance of discovering G-quadruplex structure was described through the statement, “If G-quadruplexes form so readily
3842:"8-Oxo-7,8-dihydro-2'-deoxyguanosine and abasic site tandem lesions are oxidation prone yielding hydantoin products that strongly destabilize duplex DNA" 593:
Current therapeutic research actively focuses on targeting this stabilization of G-quadruplex structures to arrest unregulated cell growth and division.
5990:
Pieretti M, Zhang FP, Fu YH, Warren ST, Oostra BA, Caskey CT, Nelson DL (August 1991). "Absence of expression of the FMR-1 gene in fragile X syndrome".
857:
terminals. Mutations of the C9orf72 gene have been linked to the development of FTD and ALS. These two diseases have a causal relationship to GGGGCC (G
189:
proteins, and other environmental conditions and stresses affect the dynamic formation of quadruplexes. For instance, quantitative assessments of the
5030:
Brázda, Václav; Kolomazník, Jan; Lýsek, Jiří; Bartas, Martin; Fojta, Miroslav; Šťastný, Jiří; Mergny, Jean-Louis (2019-09-15). Hancock, John (ed.).
3126:"Telomere Repeat-Binding Factor 2 Binds Extensively to Extra-Telomeric G-quadruplexes and Regulates the Epigenetic Status of Several Gene Promoters" 3946:"Human Apurinic/Apyrimidinic Endonuclease (APE1) Is Acetylated at DNA Damage Sites in Chromatin, and Acetylation Modulates Its DNA Repair Activity" 2116:
Miyoshi D, Karimata H, Sugimoto N (June 2006). "Hydration regulates thermodynamics of G-quadruplex formation under molecular crowding conditions".
5784:
Haeusler AR, Donnelly CJ, Periz G, Simko EA, Shaw PG, Kim MS, Maragakis NJ, Troncoso JC, Pandey A, Sattler R, Rothstein JD, Wang J (March 2014).
5735:"The disease-associated r(GGGGCC)n repeat from the C9orf72 gene forms tract length-dependent uni- and multimolecular RNA G-quadruplex structures" 2994:"Metastases Suppressor NM23-H2 Interaction With G-quadruplex DNA Within c-MYC Promoter Nuclease Hypersensitive Element Induces c-MYC Expression" 916:. FMRP acts as a negative regulator of translation, and its binding stabilizes G-quadruplex structures in mRNA transcripts, inhibiting ribosome 3500: 806:
can detect G-quadruplexes based on size exclusion and specific interaction of G-quadruplex and protein nanocavity. The novel approach combines
662:
One way of inducing or stabilizing G-quadruplex formation is to introduce a molecule which can bind to the G-quadruplex structure. A number of
350:-wide surveys based on a quadruplex folding rule have been performed, which have identified 376,000 Putative Quadruplex Sequences (PQS) in the 1231:
Sen D, Gilbert W (July 1988). "Formation of parallel four-stranded complexes by guanine-rich motifs in DNA and its implications for meiosis".
486:
shift from the original damage guanine, 8-oxo-Gua, and represents DNA damage that causes changes in the structure. This form allows for the
2917:"The DEXH protein product of the DHX36 gene is the major source of tetramolecular quadruplex G4-DNA resolving activity in HeLa cell lysates" 205:. In addition, the propensity of g-quadruplex formation during transcription in RNA sequences with the potential to form mutually exclusive 3699:"Stimulation of human 8-oxoguanine-DNA glycosylase by AP-endonuclease: potential coordination of the initial steps in base excision repair" 2659:"An intramolecular G-quadruplex structure with mixed parallel/antiparallel G-strands formed in the human BCL-2 promoter region in solution" 977: 81:, or tetramolecular. Depending on the direction of the strands or parts of a strand that form the tetrads, structures may be described as 6576:
Campbell NH, Patel M, Tofa AB, Ghosh R, Parkinson GN, Neidle S (March 2009). "Selectivity in ligand recognition of G-quadruplex loops".
5419:
Bošković F, Zhu J, Chen K, Keyser UF (November 2019). "Monitoring G-Quadruplex Formation with DNA Carriers and Solid-State Nanopores".
3075:"Epigenetic Suppression of Human Telomerase ( hTERT) Is Mediated by the Metastasis Suppressor NME2 in a G-quadruplex-dependent Fashion" 909:
within the nucleus, and separation of nucleolin by the mutated RNA transcripts impairs nucleolar function and ribosomal RNA synthesis.
893:
repeats in DNA have the ability to form mixed parallel-antiparallel G-quadruplex structures as well. These RNA transcripts containing G
7098: 1494:"QuadBase: Genome-Wide Database of G4 DNA--occurrence and Conservation in Human, Chimpanzee, Mouse and Rat Promoters and 146 Microbes" 4905:"Intramolecularly folded G-quadruplex and i-motif structures in the proximal promoter of the vascular endothelial growth factor gene" 2858:"The Werner syndrome protein is distinguished from the Bloom syndrome protein by its capacity to tightly bind diverse DNA structures" 928:, and other neurological disorders. Specifically, Fragile X Syndrome is caused by an increase from 50 to over 200 CGG repeats within 457:(OGG1), APE1 and G-quadruplex play a huge role in its repair. These enzymes participate in BER to repair certain DNA lesions such as 3041:
Borman S (November 2009). "Promoter Quadruplexes Folded DNA structures in gene-activation sites may be useful cancer drug targets".
1639:
Borman S (November 2009). "Promoter quadruplexes folded DNA structures in gene-activation sites may be useful cancer drug targets".
976:
and bind them leading to the regulation of gene expression. Decoys have been successfully demonstrated to inhibit oncogenic KRAS in
2018:"G-Quadruplexes Involving Both Strands of Genomic DNA Are Highly Abundant and Colocalize with Functional Sites in the Human Genome" 1017:"G-quadruplex DNA sequences are evolutionarily conserved and associated with distinct genomic features in Saccharomyces cerevisiae" 924:
and controlling the timing of the transcript's expression. Mutations of this gene can cause the development of Fragile X Syndrome,
633:
this pathway suggested the formation of a G-quadruplex in the promoter region and an applicable target for therapeutic treatments.
5678:"C9orf72 hexanucleotide repeat associated with amyotrophic lateral sclerosis and frontotemporal dementia forms RNA G-quadruplexes" 2243:"G-quadruplex formation at the 3' end of telomere DNA inhibits its extension by telomerase, polymerase and unwinding by helicase" 6973:"Direct evidence for a G-quadruplex in a promoter region and its targeting with a small molecule to repress c-MYC transcription" 4723:"Direct evidence for a G-quadruplex in a promoter region and its targeting with a small molecule to repress c-MYC transcription" 2551:"Direct evidence for a G-quadruplex in a promoter region and its targeting with a small molecule to repress c-MYC transcription" 7230:
Quadfinder: Tool for Prediction and Analysis of G Quadruplex Motifs in DNA/RNA Sequences from Maiti's group, IGIB, Delhi, India
6697:
Vilar R (2018). "Chapter 12. Nucleic Acid Quadruplexes and Metallo-Drugs". In Sigel A, Sigel H, Freisinger E, Sigel RK (eds.).
6444:"Allele-selective inhibition of mutant huntingtin expression with antisense oligonucleotides targeting the expanded CAG repeat" 4341:
Sharma S, Mukherjee AK, Roy SS, Bagri S, Lier S, Verma M, Sengupta A, Kumar M, Nesse G, Pandey DP, Chowdhury S (January 2020).
7210: 7108: 6393:
Carroll JB, Warby SC, Southwell AL, Doty CN, Greenlee S, Skotte N, Hung G, Bennett CF, Freier SM, Hayden MR (December 2011).
3460: 1148: 885:
repeats. The transcribed RNA of these repeats have been shown to form stable G-quadruplexes, with evidence showing that the G
831:(FTD). The second mechanism is through mutations that affect the expression of G-quadruplex binding proteins, as seen in the 4431:"Transcription Regulation of CDKN1A (p21/CIP1/WAF1) by TRF2 Is Epigenetically Controlled Through the REST Repressor Complex" 2153:"Molecular crowding creates an essential environment for the formation of stable G-quadruplexes in long double-stranded DNA" 3124:
Mukherjee AK, Sharma S, Bagri S, Kutum R, Kumar P, Hussain A, Singh P, Saha D, Kar A, Dash D, Chowdhury S (November 2019).
7195: 3995:"Regulatory role of human AP-endonuclease (APE1/Ref-1) in YB-1-mediated activation of the multidrug resistance gene MDR1" 389:
strand helps to maintain an open conformation of the coding DNA strand and enhance an expression of the respective gene.
6277:
Wheeler TM, Leger AJ, Pandey SK, MacLeod AR, Nakamori M, Cheng SH, Wentworth BM, Bennett CF, Thornton CA (August 2012).
4524:"Formation of pseudosymmetrical G-quadruplex and i-motif structures in the proximal promoter region of the RET oncogene" 4199: 2292:"In vitro generated antibodies specific for telomeric guanine-quadruplex DNA react with Stylonychia lemnae macronuclei" 1175:
Sundquist WI, Klug A (December 1989). "Telomeric DNA dimerizes by formation of guanine tetrads between hairpin loops".
333: 4342: 605:
regulation reported to be mediated through interaction of hTERT promoter G-quadruplex with the telomeric factor TRF2.
7172:– a website to discuss publications and other information of interest to those working in the field of G-quadruplexes 6714: 5242: 5573:
BL, Boeve BF, Uitti RJ, Boylan KB, Wszolek ZK, Graff-Radford NR, Dickson DW, Ross OA, Rademakers R (December 2012).
7213:- a web server to predict G-quadruplex forming motifs and other non-B DNA forming motifs from users' DNA sequences. 814:
for label-free detection of G-quadruplexes, for their mapping on dsDNA, and for monitoring G-quadruplex formation.
598: 31: 5135: 1969:"Computational detection and analysis of sequences with duplex-derived interstrand G-quadruplex forming potential" 6170:"Targeted degradation of sense and antisense C9orf72 RNA foci as therapy for ALS and frontotemporal degeneration" 5511: 2709:
Fernando H, Reszka AP, Huppert J, Ladame S, Rankin S, Venkitaraman AR, Neidle S, Balasubramanian S (June 2006).
7241:
pqsfinder: an exhaustive and imperfection-tolerant search tool for potential quadruplex-forming sequences in R.
7175: 7024:
Rawal P, Kummarasetti VB, Ravindran J, Kumar N, Halder K, Sharma R, Mukerji M, Das SK, Chowdhury S (May 2006).
4141: 2807:
Rawal P, Kummarasetti VB, Ravindran J, Kumar N, Halder K, Sharma R, Mukerji M, Das SK, Chowdhury S (May 2006).
398: 265:
determination. The formation of these quadruplexes in telomeres has been shown to decrease the activity of the
940:
modifications of FMR1 that prevent the transcription of the gene, leading to pathological low levels of FMRP.
601:. Interaction of c-Myc promoter G-quadruplex with NM23H2 was shown to regulate c-Myc in cancer cells in 2009 992: 824: 5362:"Single-molecule investigation of G-quadruplex folds of the human telomere sequence in a protein nanocavity" 3073:
Saha D, Singh A, Hussain T, Srivastava V, Sengupta S, Kar A, Dhapola P, Ummanni R, Chowdhury S (July 2017).
1289:
Rawal P, Kummarasetti VB, Ravindran R, Kumar N, Halder K, Sharma R, Mukerji M, Das SK, Chowdhury S (2006).
7181: 2992:
Thakur RK, Kumar P, Halder K, Verma A, Kar A, Parent JL, Basundra R, Kumar A, Chowdhury S (January 2009).
2915:
Vaughn JP, Creacy SD, Routh ED, Joyner-Butt C, Jenkins GS, Pauli S, Nagamine Y, Akman SA (November 2005).
917: 7224:
QGRS Mapper: a web-based application for predicting G-quadruplexes in nucleotide sequences and NCBI genes
5933:"Translational regulation of the human achaete-scute homologue-1 by fragile X mental retardation protein" 4343:"Human Telomerase Expression is under Direct Transcriptional Control of the Telomere-binding-factor TRF2" 1345:
Borman S (May 28, 2007). "Ascent of quadruplexes nucleic acid structures become promising drug targets".
86: 4666:"A G-quadruplex-binding compound showing anti-tumour activity in an in vivo model for pancreatic cancer" 3529:"Endogenous oxidized DNA bases and APE1 regulate the formation of G-quadruplex structures in the genome" 475: 5529:
Ratnavalli E, Brayne C, Dawson K, Hodges JR (June 2002). "The prevalence of frontotemporal dementia".
3283:
Chen MC, Tippana R, Demeshkina NA, Murat P, Balasubramanian S, Myong S, Ferré-D'Amaré AR (June 2018).
2400:
single-stranded DNA self-condenses into compact beaded filaments stabilized by G-quadruplex formation"
5031: 4044:"Role of acetylated human AP-endonuclease (APE1/Ref-1) in regulation of the parathyroid hormone gene" 2711:"A conserved quadruplex motif located in a transcription activation site of the human c-kit oncogene" 478:(8-oxo-dG), is a known major product of DNA oxidation. Its concentration is used as a measurement of 6752: 6230:"Targeting RNA foci in iPSC-derived motor neurons from ALS patients with a C9ORF72 repeat expansion" 4239: 4091:
Yamamori T, DeRicco J, Naqvi A, Hoffman TA, Mattagajasingh I, Kasuno K, et al. (January 2010).
303:
hypersensitive region critical for gene activity. Other genes shown to form G-quadruplexes in their
7026:"Genome-wide prediction of G4 DNA as regulatory motifs: role in Escherichia coli global regulation" 3746:
Burrows CJ, Muller JG (May 1998). "Oxidative Nucleobase Modifications Leading to Strand Scission".
2809:"Genome-wide prediction of G4 DNA as regulatory motifs: role in Escherichia coli global regulation" 1768:
Müller, Sebastian; Kumari, Sunita; Rodriguez, Raphaël; Balasubramanian, Shankar (10 October 2010).
1408:
Han H, Hurley LH (April 2000). "G-quadruplex DNA: a potential target for anti-cancer drug design".
1291:"Genome-wide Prediction of G4 DNA as Regulatory Motifs: Role in Escherichia Coli Global Regulation" 382: 3389:
Hänsel-Hertsch R, Beraldi D, Lensing SV, Marsico G, Zyner K, Parry A, et al. (October 2016).
2451:"G-Quadruplex in Gene Encoding Large Subunit of Plant RNA Polymerase II: A Billion-Year-Old Story" 369:. There are several possible models for how quadruplexes could influence gene activity, either by 5088: 1127: 828: 272:, which is responsible for maintaining length of telomeres and is involved in around 85% of all 5931:
Fähling M, Mrowka R, Steege A, Kirschner KM, Benko E, Förstera B, et al. (February 2009).
5676:
Fratta P, Mizielinska S, Nicoll AJ, Zloh M, Fisher EM, Parkinson G, Isaacs AM (December 2012).
5472:"G-quadruplexes: Emerging roles in neurodegenerative diseases and the non-coding transcriptome" 3527:
Roychoudhury S, Pramanik S, Harris HL, Tarpley M, Sarkar A, Spagnol G, et al. (May 2020).
538: 534: 491: 454: 406: 6070:"C9orf72 amyotrophic lateral sclerosis and frontotemporal dementia: gain or loss of function?" 5843:"Fragile X mental retardation protein targets G quartet mRNAs important for neuronal function" 1076:"A G-quadruplex DNA-affinity Approach for Purification of Enzymaticacvly Active G4 Resolvase1" 7259: 4781: 440:, was utilized to map both; damage in AP sites, and the enzyme responsible for its repair, 209:
or G-quadruplex structures depends heavily on the position of the hairpin-forming sequence.
7114: 6984: 6347: 6290: 6181: 5797: 5689: 5428: 5373: 4961: 4734: 4677: 4442: 3993:
Chattopadhyay R, Das S, Maiti AK, Boldogh I, Xie J, Hazra TK, et al. (December 2008).
3540: 3296: 3239: 2869: 2562: 2449:
Volná A, Bartas M, KarlickĂ˝ V, Nezval J, Kundrátová K, PeÄŤinka P, et al. (July 2021).
2303: 2029: 1781: 1679: 1240: 1184: 1028: 973: 702:
TMPyP4, a cationic porphyrin, is a more well known G4 binding ligand that helps to repress
543: 487: 450: 74: 70: 5972: 3944:
Roychoudhury S, Nath S, Song H, Hegde ML, Bellot LJ, Mantha AK, et al. (March 2017).
8: 5590: 3610: 913: 610: 414: 198: 105:
structures with a high association of guanines, which was later identified in eukaryotic
82: 66: 39: 6988: 6611:
Ohnmacht SA, Neidle S (June 2014). "Small-molecule quadruplex-targeted drug discovery".
6351: 6294: 6185: 6120:"RNA toxicity from the ALS/FTD C9ORF72 expansion is mitigated by antisense intervention" 5801: 5693: 5432: 5377: 4965: 4881: 4738: 4681: 4446: 3544: 3300: 3243: 2873: 2566: 2307: 2033: 1828:"Small-molecule–induced DNA damage identifies alternative DNA structures in human genes" 1785: 1683: 1244: 1188: 1032: 7050: 7025: 6954: 6929: 6911: 6886: 6868: 6843: 6825: 6800: 6740: 6728: 6674: 6647: 6553: 6528: 6468: 6443: 6419: 6394: 6370: 6335: 6311: 6278: 6254: 6229: 6204: 6169: 6144: 6119: 6094: 6069: 6015: 5872: 5818: 5785: 5761: 5734: 5710: 5677: 5653: 5628: 5599: 5574: 5554: 5452: 5396: 5361: 5342: 5253: 5116: 5064: 4985: 4929: 4904: 4845: 4820: 4698: 4665: 4646: 4597: 4572: 4548: 4523: 4463: 4430: 4405: 4380: 4361: 4279: 4254: 4227: 4210: 4117: 4092: 4019: 3994: 3970: 3945: 3918: 3893: 3866: 3841: 3814: 3789: 3671: 3646: 3619: 3594: 3563: 3528: 3494: 3482: 3418: 3366: 3341: 3317: 3284: 3260: 3227: 3203: 3176: 3152: 3125: 3101: 3074: 3018: 2993: 2892: 2857: 2833: 2808: 2784: 2759: 2735: 2710: 2683: 2658: 2634: 2609: 2477: 2450: 2426: 2393: 2374: 2267: 2242: 2177: 2152: 2052: 2017: 1993: 1968: 1944: 1919: 1900: 1852: 1827: 1802: 1769: 1750: 1616: 1591: 1567: 1542: 1518: 1493: 1469: 1444: 1315: 1290: 1264: 1208: 1100: 1075: 1051: 1016: 836: 811: 378: 304: 194: 7007: 6972: 5859: 5842: 5575:"Length of normal alleles of C9ORF72 GGGGCC repeat do not influence disease phenotype" 5329: 5312: 5202: 5177: 4782:"Structural basis for telomeric G-quadruplex targeting by naphthalene diimide ligands" 4780:
Collie GW, Promontorio R, Hampel SM, Micco M, Neidle S, Parkinson GN (February 2012).
4757: 4722: 4184:
Sequence, stability, and structure of G-quadruplexes and their interactions with drugs
4068: 4043: 3390: 2585: 2550: 2526: 2501: 1702: 1667: 1421: 238:
repeats in a variety of organisms have been shown to form these quadruplex structures
57:, which sits in a central channel between each pair of tetrads. They can be formed of 7139: 7104: 7085: 7055: 7012: 6959: 6916: 6873: 6830: 6787: 6720: 6710: 6679: 6628: 6593: 6558: 6509: 6473: 6424: 6375: 6316: 6259: 6209: 6149: 6099: 6050: 6007: 6003: 5954: 5913: 5864: 5823: 5766: 5715: 5658: 5604: 5546: 5493: 5456: 5444: 5401: 5334: 5293: 5258: 5238: 5207: 5158: 5108: 5069: 5051: 5012: 4977: 4934: 4885: 4850: 4801: 4762: 4703: 4638: 4602: 4553: 4504: 4468: 4410: 4365: 4323: 4284: 4270: 4215: 4195: 4164: 4122: 4073: 4024: 3975: 3923: 3871: 3819: 3763: 3728: 3723: 3698: 3676: 3624: 3568: 3486: 3474: 3466: 3456: 3410: 3371: 3322: 3265: 3208: 3157: 3106: 3023: 2938: 2897: 2838: 2789: 2740: 2688: 2639: 2590: 2531: 2482: 2431: 2366: 2331: 2326: 2291: 2272: 2223: 2182: 2133: 2098: 2057: 1998: 1949: 1892: 1857: 1807: 1742: 1738: 1707: 1621: 1572: 1523: 1474: 1425: 1390: 1320: 1256: 1200: 1154: 1144: 1105: 1056: 960: 677:
have been shown to bind intercalatively with G-quadruplexes, as well as the molecule
262: 140: 6732: 6019: 5558: 5120: 5047: 4650: 3422: 1904: 1754: 584:
regions of DNA, G-quadruplex structures have been identified in various human proto-
385:
of the gene, and hence de-activating it. In another model, quadruplex formed at the
7131: 7077: 7045: 7037: 7002: 6992: 6949: 6941: 6906: 6898: 6863: 6855: 6820: 6812: 6779: 6702: 6669: 6659: 6620: 6585: 6548: 6540: 6501: 6463: 6455: 6414: 6406: 6365: 6355: 6306: 6298: 6249: 6241: 6199: 6189: 6139: 6131: 6089: 6081: 6042: 5999: 5944: 5903: 5892:"Phosphorylation influences the translation state of FMRP-associated polyribosomes" 5876: 5854: 5813: 5805: 5756: 5746: 5705: 5697: 5648: 5640: 5594: 5586: 5538: 5483: 5436: 5391: 5381: 5346: 5324: 5285: 5248: 5230: 5197: 5189: 5150: 5100: 5089:"G4RNA screener web server: User focused interface for RNA G-quadruplex prediction" 5059: 5043: 4989: 4969: 4924: 4916: 4877: 4840: 4832: 4793: 4752: 4742: 4693: 4685: 4630: 4592: 4584: 4543: 4535: 4496: 4458: 4450: 4400: 4392: 4353: 4315: 4274: 4266: 4205: 4187: 4156: 4112: 4104: 4063: 4055: 4014: 4006: 3965: 3957: 3913: 3905: 3861: 3853: 3809: 3801: 3755: 3718: 3710: 3666: 3658: 3614: 3606: 3558: 3548: 3448: 3402: 3361: 3353: 3312: 3304: 3255: 3247: 3198: 3188: 3147: 3137: 3096: 3086: 3050: 3013: 3005: 2969: 2928: 2887: 2877: 2828: 2820: 2779: 2771: 2730: 2722: 2678: 2670: 2657:
Dai J, Dexheimer TS, Chen D, Carver M, Ambrus A, Jones RA, Yang D (February 2006).
2629: 2621: 2580: 2570: 2521: 2513: 2472: 2462: 2421: 2411: 2378: 2358: 2321: 2311: 2262: 2254: 2213: 2172: 2164: 2125: 2088: 2047: 2037: 1988: 1980: 1939: 1931: 1884: 1847: 1839: 1797: 1789: 1734: 1697: 1687: 1648: 1611: 1603: 1562: 1554: 1543:"QuadBase2: Web Server for Multiplexed Guanine Quadruplex Mining and Visualization" 1513: 1505: 1464: 1456: 1417: 1382: 1354: 1310: 1302: 1268: 1248: 1212: 1192: 1136: 1095: 1087: 1046: 1036: 854: 711: 517: 516:
alterations, or the modulation of gene expression. Upon insertion of 8-oxo-dG into
479: 23:
Structure of a G-quadruplex. Left: a G-tetrad. Right: an intramolecular G4 complex.
6801:"In vivo veritas: using yeast to probe the biological functions of G-quadruplexes" 5488: 5471: 5154: 2200:
Endoh T, Rode AB, Takahashi S, Kataoka Y, Kuwahara M, Sugimoto N (February 2016).
1074:
Routh ED, Creacy SD, Beerbower PE, Akman SA, Vaughn JP, Smaldino PJ (March 2017).
7199: 6816: 6245: 6135: 6085: 5440: 5104: 5003:
Smith SS (2010). "Evolutionary expansion of structurally complex DNA sequences".
4191: 4160: 3595:"Base excision DNA repair levels in mitochondrial lysates of Alzheimer's disease" 3193: 2882: 2290:
Schaffitzel C, Berger I, Postberg J, Hanes J, Lipps HJ, PlĂĽckthun A (July 2001).
2218: 2201: 2042: 1041: 968: 937: 933: 496: 445: 441: 437: 426: 5289: 5234: 4634: 3452: 1984: 1875:
Simonsson T (April 2001). "G-quadruplex DNA structures--variations on a theme".
1140: 7234: 6977:
Proceedings of the National Academy of Sciences of the United States of America
6624: 6340:
Proceedings of the National Academy of Sciences of the United States of America
6174:
Proceedings of the National Academy of Sciences of the United States of America
5644: 5512:"C9orf72 chromosome 9 open reading frame 72 [Homo sapiens] - Gene]" 5366:
Proceedings of the National Academy of Sciences of the United States of America
4727:
Proceedings of the National Academy of Sciences of the United States of America
4454: 3892:
Kitsera N, Rodriguez-Alvarez M, Emmert S, Carell T, Khobta A (September 2019).
3805: 3533:
Proceedings of the National Academy of Sciences of the United States of America
3447:. Methods in Molecular Biology. Vol. 2175. Clifton, N.J. pp. 95–108. 3441:"AP-Seq: A Method to Measure Apurinic Sites and Small Base Adducts Genome-Wide" 3357: 2555:
Proceedings of the National Academy of Sciences of the United States of America
2296:
Proceedings of the National Academy of Sciences of the United States of America
1672:
Proceedings of the National Academy of Sciences of the United States of America
1358: 972:
properties. When introduced to cancer cells the decoy can intercept associated
509: 409:
have a high affinity for resolving DNA G-quadruplexes. The DEAH/RHA helicase,
386: 374: 311: 190: 43: 7192: 7135: 6706: 5841:
Darnell JC, Jensen KB, Jin P, Brown V, Warren ST, Darnell RB (November 2001).
5627:, Tabrizi SJ, Isaacs AM, Hardy J, Warren JD, Collinge J, Mead S (March 2013). 4357: 3308: 3054: 2093: 2076: 1652: 901:
repeats were shown to bind and separate a wide variety of proteins, including
464: 7253: 5786:"C9orf72 nucleotide repeat structures initiate molecular cascades of disease" 5624: 5229:. Methods in Molecular Biology. Vol. 608. Humana Press. pp. 65–79. 5055: 4522:
Guo K, Pourpak A, Beetz-Rogers K, Gokhale V, Sun D, Hurley LH (August 2007).
3470: 3142: 2416: 1445:"DNA secondary structures: stability and function of G-quadruplex structures" 474:
having a lower electron reduction potential than the other nucleotides bases,
341: 337: 322: 293: 6664: 6360: 6194: 5890:
Ceman S, O'Donnell WT, Reed M, Patton S, Pohl J, Warren ST (December 2003).
5751: 5386: 3553: 3440: 3091: 2517: 1692: 877:
repeats, but individuals with FTD or ALS have from 500 to several thousand G
7269: 7264: 7186: 7143: 7089: 7059: 7016: 6997: 6963: 6920: 6877: 6834: 6791: 6724: 6683: 6632: 6597: 6562: 6513: 6477: 6428: 6379: 6320: 6263: 6213: 6153: 6103: 5958: 5949: 5932: 5917: 5868: 5827: 5770: 5719: 5662: 5608: 5550: 5542: 5497: 5448: 5405: 5297: 5262: 5193: 5162: 5112: 5073: 5016: 4938: 4854: 4805: 4766: 4747: 4707: 4642: 4606: 4557: 4508: 4472: 4414: 4327: 4288: 4219: 4168: 4126: 4077: 4059: 4028: 3979: 3927: 3875: 3823: 3767: 3732: 3714: 3680: 3628: 3572: 3478: 3414: 3375: 3326: 3285:"Structural basis of G-quadruplex unfolding by the DEAH/RHA helicase DHX36" 3269: 3212: 3161: 3110: 3027: 2942: 2933: 2916: 2901: 2842: 2793: 2744: 2692: 2643: 2594: 2575: 2486: 2435: 2370: 2335: 2316: 2276: 2227: 2186: 2137: 2102: 2061: 2002: 1953: 1896: 1861: 1811: 1711: 1625: 1576: 1527: 1478: 1429: 1394: 1324: 1158: 1109: 1060: 691: 678: 618: 530: 458: 402: 370: 277: 6054: 6046: 6011: 5338: 5211: 5136:"G-Quadruplexes: Prediction, Characterization, and Biological Application" 4981: 4889: 4255:"Making sense of G-quadruplex and i-motif functions in oncogene promoters" 4108: 3228:"Quantitative visualization of DNA G-quadruplex structures in human cells" 2625: 2535: 1746: 1260: 1204: 7223: 7205: 6945: 6902: 6859: 6544: 6527:
Cogoi S, Zorzet S, Rapozzi V, GĂ©ci I, Pedersen EB, Xodo LE (April 2013).
5908: 5891: 4920: 4836: 4588: 4396: 4010: 3961: 3909: 3790:"The genomics of oxidative DNA damage, repair, and resulting mutagenesis" 3009: 2974: 2957: 2775: 2467: 2258: 2168: 1935: 1843: 1607: 1558: 1509: 1135:. Metal Ions in Life Sciences. Vol. 16. Springer. pp. 203–258. 988: 362: 78: 6410: 6336:"RNase H-mediated degradation of toxic RNA in myotonic dystrophy type 1" 6302: 5809: 5087:
Garant, Jean-Michel; Perreault, Jean-Pierre; Scott, Michelle S. (2018).
4619: 2241:
Wang Q, Liu JQ, Chen Z, Zheng KW, Chen CY, Hao YH, Tan Z (August 2011).
1888: 7041: 6783: 5571: 3857: 3251: 3225: 2824: 1306: 752: 569: 561: 513: 269: 251: 223: 202: 118: 7081: 6589: 6505: 6459: 5733:
Reddy K, Zamiri B, Stanley SY, Macgregor RB, Pearson CE (April 2013).
5701: 4797: 4689: 4539: 4500: 4319: 3759: 3662: 3068: 3066: 3064: 2987: 2985: 2726: 2674: 2129: 1793: 1386: 144: 7246:
pqsfinder: online search tool using the latest R/Bioconductor package
4973: 4093:"SIRT1 deacetylates APE1 and regulates cellular base excision repair" 2202:"Real-Time Monitoring of G-Quadruplex Formation during Transcription" 1340: 1338: 1336: 1334: 1284: 1282: 1280: 1278: 1252: 1196: 983:
Another commonly used technique is the utilization of small-molecule
980:
leading to reduced tumour growth and increased median survival time.
902: 850: 764: 760: 674: 646: 533:. Once the cell is aware of oxidative stress and damage, it recruits 419: 377:. One model is shown below, with G-quadruplex formation in or near a 318: 214: 182: 54: 7169: 6279:"Targeting nuclear RNA for in vivo correction of myotonic dystrophy" 5178:"A DNA polymerase stop assay for G-quadruplex-interactive compounds" 5032:"G4Hunter web application: a web server for G-quadruplex prediction" 3891: 3406: 3226:
Biffi G, Tannahill D, McCafferty J, Balasubramanian S (March 2013).
2362: 1767: 1460: 133: 7229: 6887:"Highly prevalent putative quadruplex sequence motifs in human DNA" 5470:
Simone R, Fratta P, Neidle S, Parkinson GN, Isaacs AM (June 2015).
4821:"Highly prevalent putative quadruplex sequence motifs in human DNA" 3388: 3061: 2982: 921: 906: 799: 585: 581: 565: 483: 300: 289: 240: 235: 201:
bonding. These quadruplexes seemed to readily occur at the ends of
106: 6971:
Siddiqui-Jain A, Grand CL, Bearss DJ, Hurley LH (September 2002).
4868:
Frank-Kamenetskii MD, Mirkin SM (1995). "Triplex DNA structures".
4721:
Siddiqui-Jain A, Grand CL, Bearss DJ, Hurley LH (September 2002).
2549:
Siddiqui-Jain A, Grand CL, Bearss DJ, Hurley LH (September 2002).
1331: 1275: 1091: 869:
of C9orf72 gene. Normal individuals typically have around 2 to 8 G
4663: 3526: 1770:"Small-molecule-mediated G-quadruplex isolation from human cells" 1492:
Yadav VK, Abraham JK, Mani P, Kulshrestha R, Chowdhury S (2008).
984: 954: 949: 843: 756: 696: 667: 537:
to the site, whose main function is to initiate the BER pathway.
471: 432: 308: 246: 206: 186: 159: 98: 35: 7236:
G4Hunter from Mergny's group but user need to run the code in R.
4951: 4042:
Bhakat KK, Izumi T, Yang SH, Hazra TK, Mitra S (December 2003).
397:
It has been suggested that quadruplex formation plays a role in
7244: 7023: 6441: 6226: 2806: 2348: 1288: 925: 866: 847: 663: 629: 461:(8-oxoG), which forms under oxidative stress to guanine bases. 361:. A similar studies have identified putative G-quadruplexes in 354: 347: 273: 266: 178: 50: 34:(G4) are formed in nucleic acids by sequences that are rich in 19: 7163: 6970: 4720: 2548: 2289: 2077:"Existence and consequences of G-quadruplex structures in DNA" 1824: 444:(APE1). Both of these genome-wide mapping sequencing methods, 427:
Genome Regulation through formation of G-quadruplex structures
6646:
Zamiri B, Reddy K, Macgregor RB, Pearson CE (February 2014).
4521: 686: 410: 351: 329: 325: 296: 259: 7121: 7096: 6490: 6166: 6032: 5930: 5889: 5528: 4779: 4571:
Qin Y, Rezler EM, Gokhale V, Sun D, Hurley LH (2007-11-26).
3992: 2914: 2392:
Kar A, Jones N, Arat NĂ–, Fishel R, Griffith JD (June 2018).
42:
hydrogen bonding to form a square planar structure called a
7178:– a database listing potential G-quadruplex regulated genes 6645: 5732: 5675: 5469: 5360:
An N, Fleming AM, Middleton EG, Burrows CJ (October 2014).
5029: 4427: 4090: 3592: 2708: 1491: 929: 905:. Nucleolin is involved in the synthesis and maturation of 832: 465:
Role of Endogenous Oxidized DNA Base Damage on G4 formation
314: 6928:
Burge S, Parkinson GN, Hazel P, Todd AK, Neidle S (2006).
6799:
Johnson JE, Smith JS, Kozak ML, Johnson FB (August 2008).
6699:
Metallo-Drugs: Development and Action of Anticancer Agents
5783: 3593:
Canugovi C, Shamanna RA, Croteau DL, Bohr VA (June 2014).
3282: 3072: 1918:
Burge S, Parkinson GN, Hazel P, Todd AK, Neidle S (2006).
172: 7189:- a database of G-quadruplexes near RNA processing sites. 6392: 6276: 6116: 5359: 3943: 3391:"G-quadruplex structures mark human regulatory chromatin" 3123: 2856:
Kamath-Loeb A, Loeb LA, Fry M (2012). Cotterill S (ed.).
2610:"G-quadruplexes in promoters throughout the human genome" 2448: 2199: 1724: 1073: 255: 102: 62: 58: 6798: 5621: 2502:"DNA tetraplex formation in the control region of c-myc" 1014: 288:
Quadruplexes are present in locations other than at the
276:. This is an active target of drug discovery, including 250:. The human telomeric repeat (which is the same for all 7217: 6927: 4867: 4340: 4142:"Quadruplex Nucleic Acids as Novel Therapeutic Targets" 2499: 2115: 1917: 7182:
Database on Quadruplex information: QuadBase from IGIB
6841: 6575: 6526: 5275: 4485: 3434: 3432: 2991: 2757: 2656: 2607: 1592:"G-quadruplexes and their regulatory roles in biology" 1371: 1015:
Capra JA, Paeschke K, Singh M, Zakian VA (July 2010).
775: 121:, Nobel Prize Winner in Chemistry (1982). Interest in 5989: 5840: 5418: 3342:"Structure and function of the telomeric CST complex" 3175:
Maizels N, Gray LT (April 2013). Rosenberg SM (ed.).
2955: 1442: 650:
inhibits cancer growth more effectively than TMPyP4.
244:, and subsequently they have also been shown to form 5086: 4252: 4041: 3697:
Hill JW, Hazra TK, Izumi T, Mitra S (January 2001).
2074: 1665: 953:
expression of a gene; this has been detected in the
948:
Antisense-mediated interventions and small-molecule
932:
13 of the FMR1 gene. This repeat expansion promotes
4902: 4570: 3696: 3429: 1443:Bochman ML, Paeschke K, Zakian VA (November 2012). 1125: 717: 628:The RET oncogene functions in the transcription of 6930:"Quadruplex DNA: sequence, topology and structure" 6884: 5313:"Following G-quartet formation by UV-spectroscopy" 4903:Guo K, Gokhale V, Hurley LH, Sun D (August 2008). 4818: 4378: 4253:Brooks TA, Kendrick S, Hurley L (September 2010). 3894:"Nucleotide excision repair of abasic DNA lesions" 3794:Computational and Structural Biotechnology Journal 3346:Computational and Structural Biotechnology Journal 2855: 2608:Huppert JL, Balasubramanian S (14 December 2006). 2391: 1920:"Quadruplex DNA: sequence, topology and structure" 1666:Gellert M, Lipsett MN, Davies DR (December 1962). 657: 6067: 5310: 4379:Sun D, Guo K, Rusche JJ, Hurley LH (2005-10-12). 4186:. Vol. Chapter 17. pp. 17.5.1–17.5.17. 817: 7251: 6844:"Prevalence of quadruplexes in the human genome" 6333: 5311:Mergny JL, Phan AT, Lacroix L (September 1998). 5175: 2958:"Structural Basis of DEAH/RHA Helicase Activity" 2760:"Prevalence of quadruplexes in the human genome" 2500:Simonsson T, Pecinka P, Kubista M (March 1998). 2240: 2151:Zheng KW, Chen Z, Hao YH, Tan Z (January 2010). 1966: 1540: 580:Along with the association of G-quadruplexes in 560:G-quadruplex forming sequences are prevalent in 3835: 3833: 3339: 2150: 523: 6769: 6610: 3839: 6639: 6604: 6569: 6435: 6386: 6327: 6270: 6220: 6160: 6110: 6061: 5516:National Center for Biotechnology Information 4300: 4298: 3745: 2704: 2702: 2081:Current Opinion in Genetics & Development 1174: 759:). This rule has been widely used in on-line 283: 113:, Nature will have found a way of using them 97:The identification of structures with a high 7066: 6613:Bioorganic & Medicinal Chemistry Letters 6334:Lee JE, Bennett CF, Cooper TA (March 2012). 5176:Han H, Hurley LH, Salazar M (January 1999). 3830: 3333: 2956:Chen MC, FerrĂ©-D'AmarĂ© AR (15 August 2017). 1226: 1224: 1222: 1170: 1168: 7202:- a database of G-quadruplexes in the UTRs. 5133: 3174: 2455:International Journal of Molecular Sciences 1589: 802:-based methods. Firstly, it was shown that 7097:Neidle & Balasubramanian, ed. (2006). 4304: 4295: 3499:: CS1 maint: location missing publisher ( 2699: 1868: 1230: 1121: 1119: 357:, although not all of these probably form 7049: 7006: 6996: 6953: 6910: 6867: 6824: 6673: 6663: 6552: 6467: 6418: 6369: 6359: 6310: 6253: 6203: 6193: 6143: 6093: 6068:Mizielinska S, Isaacs AM (October 2014). 5948: 5907: 5858: 5817: 5760: 5750: 5709: 5652: 5598: 5487: 5395: 5385: 5328: 5252: 5224: 5201: 5063: 4928: 4844: 4756: 4746: 4697: 4596: 4547: 4462: 4404: 4278: 4209: 4116: 4067: 4018: 3969: 3917: 3865: 3813: 3722: 3670: 3644: 3618: 3562: 3552: 3365: 3316: 3259: 3202: 3192: 3151: 3141: 3100: 3090: 3017: 2973: 2932: 2891: 2881: 2832: 2783: 2734: 2682: 2633: 2584: 2574: 2525: 2476: 2466: 2425: 2415: 2351:Nature Structural & Molecular Biology 2325: 2315: 2266: 2217: 2176: 2092: 2075:Murat P, Balasubramanian S (April 2014). 2051: 2041: 1992: 1943: 1874: 1851: 1801: 1701: 1691: 1615: 1566: 1517: 1468: 1407: 1314: 1219: 1165: 1129:The Alkali Metal Ions: Their Role in Life 1099: 1050: 1040: 943: 230: 7070:Journal of the American Chemical Society 4786:Journal of the American Chemical Society 4528:Journal of the American Chemical Society 4181: 2663:Journal of the American Chemical Society 2118:Journal of the American Chemical Society 2015: 1967:Cao K, Ryvkin P, Johnson FB (May 2012). 666:, which can be both small molecules and 132: 18: 3840:Fleming AM, Burrows CJ (October 2017). 3787: 3438: 1116: 846:which is found throughout the brain in 842:The C9orf72 gene codes for the protein 185:, composed of DNA tightly wound around 173:Structure and functional role in genome 7252: 7157: 6885:Todd AK, Johnston M, Neidle S (2005). 6842:Huppert JL, Balasubramanian S (2005). 4819:Todd AK, Johnston M, Neidle S (2005). 4139: 3887: 3885: 3783: 3781: 3779: 3777: 3692: 3690: 3640: 3638: 3588: 3586: 3584: 3582: 3522: 3520: 3518: 3516: 3514: 3512: 3510: 3040: 2758:Huppert JL, Balasubramanian S (2005). 1638: 1344: 957:(chromosome 9 open reading frame 72). 792: 783: 503:DNA Oxidation Contribution to Diseases 6696: 5002: 3939: 3937: 7218:Tools to predict G-quadruplex motifs 7164:Nanopore and Aptamer Biosensor group 7124:Bioorganic & Medicinal Chemistry 5591:10.1016/j.neurobiolaging.2012.07.005 5518:. U.S. National Library of Medicine. 5134:Kwok CK, Merrick CJ (October 2017). 3846:Organic & Biomolecular Chemistry 3611:10.1016/j.neurobiolaging.2014.01.004 1541:Dhapola P, Chowdhury S (July 2016). 7211:non-B Motif Search Tool at non-B DB 6652:The Journal of Biological Chemistry 5937:The Journal of Biological Chemistry 5739:The Journal of Biological Chemistry 4882:10.1146/annurev.bi.64.070195.000433 3882: 3774: 3687: 3635: 3579: 3507: 3130:The Journal of Biological Chemistry 3079:The Journal of Biological Chemistry 2921:The Journal of Biological Chemistry 2404:The Journal of Biological Chemistry 1590:Rhodes D, Lipps HJ (October 2015). 833:fragile X mental retardation gene 1 776:Methods for studying G-quadruplexes 575: 13: 6762: 6701:. Vol. 18. pp. 325–349. 5633:American Journal of Human Genetics 3934: 1668:"Helix formation by guanylic acid" 1410:Trends in Pharmacological Sciences 177:Following sequencing of the human 14: 7281: 7152: 4182:Chen Y, Yang D (September 2012). 1080:Journal of Visualized Experiments 6690: 6520: 6484: 6026: 5983: 5965: 5924: 5883: 5834: 5005:Cancer Genomics & Proteomics 4271:10.1111/j.1742-4658.2010.07759.x 718:Quadruplex prediction techniques 599:telomerase reverse transcriptase 5777: 5726: 5669: 5615: 5565: 5522: 5504: 5463: 5412: 5353: 5304: 5269: 5218: 5169: 5127: 5080: 5023: 4996: 4945: 4896: 4861: 4812: 4773: 4714: 4657: 4613: 4564: 4515: 4479: 4421: 4372: 4334: 4246: 4175: 4133: 4084: 4035: 3986: 3739: 3382: 3276: 3219: 3168: 3117: 3034: 2949: 2908: 2849: 2800: 2751: 2650: 2601: 2542: 2493: 2442: 2385: 2342: 2283: 2234: 2193: 2144: 2109: 2068: 2009: 1960: 1911: 1818: 1761: 1718: 1659: 1632: 1583: 1534: 1485: 1436: 999:coordination with nucleobases. 658:Ligands which bind quadruplexes 640: 7103:. Royal Society of Chemistry. 6494:Journal of Medicinal Chemistry 6234:Science Translational Medicine 5973:"Fragile X Mental Retardation" 4308:Journal of Medicinal Chemistry 4149:Journal of Medicinal Chemistry 3999:Molecular and Cellular Biology 3950:Molecular and Cellular Biology 3651:Journal of Medicinal Chemistry 3340:Rice C, Skordalakes E (2016). 1401: 1375:Journal of Medicinal Chemistry 1365: 1067: 1008: 818:Role in neurological disorders 455:8-Oxoguanine-DNA glycosylase 1 16:Structure in molecular biology 1: 5860:10.1016/S0092-8674(01)00566-9 5489:10.1016/j.febslet.2015.05.003 5330:10.1016/s0014-5793(98)01043-6 5155:10.1016/j.tibtech.2017.06.012 5048:10.1093/bioinformatics/btz087 4870:Annual Review of Biochemistry 3645:Sun D, Hurley LH (May 2009). 3043:Chemical and Engineering News 1641:Chemical and Engineering News 1422:10.1016/s0165-6147(00)01457-7 1347:Chemical and Engineering News 1002: 993:Amyotrophic lateral sclerosis 825:amyotrophic lateral sclerosis 6817:10.1016/j.biochi.2008.02.013 6246:10.1126/scitranslmed.3007529 6136:10.1016/j.neuron.2013.10.015 6086:10.1097/WCO.0000000000000130 6074:Current Opinion in Neurology 6004:10.1016/0092-8674(91)90125-I 5441:10.1021/acs.nanolett.9b03184 5105:10.1016/j.biochi.2018.06.002 4192:10.1002/0471142700.nc1705s50 4161:10.1021/acs.jmedchem.5b01835 3194:10.1371/journal.pgen.1003468 2883:10.1371/journal.pone.0030189 2219:10.1021/acs.analchem.5b04396 2043:10.1371/journal.pone.0146174 1739:10.1016/0092-8674(87)90577-0 1042:10.1371/journal.pcbi.1000861 555: 524:APE1 role in Gene Regulation 7: 5290:10.1016/j.ymeth.2007.02.009 5235:10.1007/978-1-59745-363-9_5 4635:10.1021/acs.biochem.8b00843 3453:10.1007/978-1-0716-0763-3_8 1985:10.1016/j.ymeth.2012.05.002 1141:10.1007/978-3-319-21756-7_7 392: 152: 10: 7286: 7206:G-quadruplex Resource Site 6625:10.1016/j.bmcl.2014.04.029 6168:Ravits J (November 2013). 5645:10.1016/j.ajhg.2013.01.011 4455:10.1038/s41598-017-11177-1 3806:10.1016/j.csbj.2019.12.013 3358:10.1016/j.csbj.2016.04.002 1359:10.1021/cen-v085n009.p012a 1021:PLOS Computational Biology 544:transcription factors (TF) 488:base excision repair (BER) 399:immunoglobulin heavy chain 284:Non-telomeric quadruplexes 92: 7136:10.1016/j.bmc.2013.09.036 6707:10.1515/9783110470734-018 4358:10.1101/2020.01.15.907626 3788:Poetsch AR (2020-01-07). 3309:10.1038/s41586-018-0209-9 3055:10.1021/cen-v087n044.p028 2394:"Long repeating (TTAGGG) 2094:10.1016/j.gde.2013.10.012 1653:10.1021/cen-v087n044.p028 865:) repeats within the 1st 550: 417:system of the pathogenic 299:forms a quadruplex in a 7100:Quadruplex Nucleic Acids 6035:Human Molecular Genetics 5896:Human Molecular Genetics 3143:10.1074/jbc.RA119.008687 2417:10.1074/jbc.RA118.002158 1449:Nature Reviews. Genetics 920:of mRNA in the neuron's 459:7,8-dihydro-8-oxoguanine 6772:Chemical Communications 6665:10.1074/jbc.C113.502336 6361:10.1073/pnas.1117019109 6195:10.1073/pnas.1318835110 5752:10.1074/jbc.C113.452532 5387:10.1073/pnas.1415944111 5143:Trends in Biotechnology 3554:10.1073/pnas.1912355117 3092:10.1074/jbc.M117.792077 1832:Nature Chemical Biology 1693:10.1073/pnas.48.12.2013 1504:(Database): D381–D385. 829:frontotemporal dementia 476:8-oxo-2'-deoxyguanosine 365:, namely the bacterium 6998:10.1073/pnas.182256799 6934:Nucleic Acids Research 6891:Nucleic Acids Research 6848:Nucleic Acids Research 6533:Nucleic Acids Research 5950:10.1074/jbc.M807354200 5543:10.1212/WNL.58.11.1615 5182:Nucleic Acids Research 4909:Nucleic Acids Research 4825:Nucleic Acids Research 4748:10.1073/pnas.182256799 4577:Nucleic Acids Research 4385:Nucleic Acids Research 4140:Neidle S (July 2016). 4097:Nucleic Acids Research 3898:Nucleic Acids Research 3703:Nucleic Acids Research 2998:Nucleic Acids Research 2934:10.1074/jbc.C500348200 2764:Nucleic Acids Research 2614:Nucleic Acids Research 2576:10.1073/pnas.182256799 2506:Nucleic Acids Research 2317:10.1073/pnas.141229498 2247:Nucleic Acids Research 2157:Nucleic Acids Research 1924:Nucleic Acids Research 1596:Nucleic Acids Research 1547:Nucleic Acids Research 1498:Nucleic Acids Research 944:Therapeutic approaches 407:Bloom syndrome protein 321:-ligase RFP2, and the 231:Telomeric quadruplexes 149: 27:In molecular biology, 24: 5579:Neurobiology of Aging 3599:Neurobiology of Aging 2518:10.1093/nar/26.5.1167 974:transcription factors 936:and other epigenetic 808:solid-state nanopores 136: 22: 5194:10.1093/nar/27.2.537 4060:10.1093/emboj/cdg595 4011:10.1128/mcb.00244-08 3962:10.1128/mcb.00401-16 3715:10.1093/nar/29.2.430 2975:10.3390/cryst7080253 2468:10.3390/ijms22147381 2206:Analytical Chemistry 2016:Kudlicki AS (2016). 1877:Biological Chemistry 1844:10.1038/nchembio.780 804:biological nanopores 451:base excision repair 307:regions include the 32:secondary structures 7226:from Bagga's group. 7158:Quadruplex websites 6989:2002PNAS...9911593S 6411:10.1038/mt.2011.201 6352:2012PNAS..109.4221L 6303:10.1038/nature11362 6295:2012Natur.488..111W 6186:2013PNAS..110E4530L 6047:10.1093/hmg/1.6.397 5810:10.1038/nature13124 5802:2014Natur.507..195H 5694:2012NatSR...2E1016F 5433:2019NanoL..19.7996B 5378:2014PNAS..11114325A 5372:(40): 14325–14331. 4966:1987Natur.330..495M 4739:2002PNAS...9911593S 4682:2015NatSR...511385O 4447:2017NatSR...711541H 4109:10.1093/nar/gkp1039 3545:2020PNAS..11711409R 3539:(21): 11409–11420. 3439:Poetsch AR (2020). 3301:2018Natur.558..465C 3244:2013NatCh...5..182B 3136:(47): 17709–17722. 3085:(37): 15205–15215. 2874:2012PLoSO...730189K 2626:10.1093/nar/gkl1057 2567:2002PNAS...9911593S 2308:2001PNAS...98.8572S 2034:2016PLoSO..1146174K 1889:10.1515/BC.2001.073 1786:2010NatCh...2.1095M 1684:1962PNAS...48.2013G 1245:1988Natur.334..364S 1189:1989Natur.342..825S 1033:2010PLSCB...6E0861C 914:synaptic plasticity 793:Biophysical methods 784:Biochemical methods 415:antigenic variation 199:Hoogsteen base pair 7198:2011-07-20 at the 7170:G-Quadruplex World 7042:10.1101/gr.4508806 6946:10.1093/nar/gkl655 6903:10.1093/nar/gki553 6860:10.1093/nar/gki609 6784:10.1039/c1cc13973h 6545:10.1093/nar/gkt127 5909:10.1093/hmg/ddg350 5682:Scientific Reports 4921:10.1093/nar/gkn380 4837:10.1093/nar/gki553 4670:Scientific Reports 4589:10.1093/nar/gkm538 4435:Scientific Reports 4397:10.1093/nar/gki917 3910:10.1093/nar/gkz558 3858:10.1039/C7OB02096A 3252:10.1038/nchem.1548 3010:10.1093/nar/gkn919 2825:10.1101/gr.4508806 2776:10.1093/nar/gki609 2259:10.1093/nar/gkr164 2169:10.1093/nar/gkp898 1936:10.1093/nar/gkl655 1608:10.1093/nar/gkv862 1559:10.1093/nar/gkw425 1510:10.1093/nar/gkm781 1307:10.1101/gr.4508806 837:Fragile X Syndrome 812:DNA nanotechnology 751:), where N is any 195:molecular crowding 150: 25: 7110:978-0-85404-374-3 7082:10.1021/ja901574c 6590:10.1021/bi802233v 6506:10.1021/jm800874t 6460:10.1021/bi101208k 6399:Molecular Therapy 6240:(208): 208ra149. 5902:(24): 3295–3305. 5796:(7491): 195–200. 5702:10.1038/srep01016 5585:(12): 2950.e5–7. 5427:(11): 7996–8001. 5042:(18): 3493–3495. 4798:10.1021/ja2102423 4690:10.1038/srep11385 4629:(46): 6514–6527. 4540:10.1021/ja072185g 4501:10.1021/bi051618u 4320:10.1021/jm200062u 4155:(13): 5987–6011. 4054:(23): 6299–6309. 4005:(23): 7066–7080. 3904:(16): 8537–8547. 3852:(39): 8341–8353. 3760:10.1021/cr960421s 3663:10.1021/jm900055s 3462:978-1-0716-0762-6 3401:(10): 1267–1272. 3295:(7710): 465–469. 2727:10.1021/bi0601510 2675:10.1021/ja055636a 2410:(24): 9473–9485. 2130:10.1021/ja061267m 1794:10.1038/nchem.842 1780:(12): 1095–1098. 1553:(W1): W277–W283. 1387:10.1021/jm800448a 1381:(18): 5641–5649. 1150:978-3-319-21755-0 961:Antisense therapy 442:AP endonuclease 1 263:crystal structure 7277: 7147: 7118: 7113:. Archived from 7093: 7063: 7053: 7020: 7010: 7000: 6967: 6957: 6924: 6914: 6881: 6871: 6838: 6828: 6795: 6757: 6756: 6750: 6746: 6744: 6736: 6694: 6688: 6687: 6677: 6667: 6643: 6637: 6636: 6608: 6602: 6601: 6573: 6567: 6566: 6556: 6539:(7): 4049–4064. 6524: 6518: 6517: 6488: 6482: 6481: 6471: 6454:(47): 10166–78. 6439: 6433: 6432: 6422: 6390: 6384: 6383: 6373: 6363: 6331: 6325: 6324: 6314: 6274: 6268: 6267: 6257: 6224: 6218: 6217: 6207: 6197: 6164: 6158: 6157: 6147: 6114: 6108: 6107: 6097: 6065: 6059: 6058: 6030: 6024: 6023: 5987: 5981: 5980: 5969: 5963: 5962: 5952: 5943:(7): 4255–4266. 5928: 5922: 5921: 5911: 5887: 5881: 5880: 5862: 5838: 5832: 5831: 5821: 5781: 5775: 5774: 5764: 5754: 5730: 5724: 5723: 5713: 5673: 5667: 5666: 5656: 5619: 5613: 5612: 5602: 5569: 5563: 5562: 5526: 5520: 5519: 5508: 5502: 5501: 5491: 5467: 5461: 5460: 5416: 5410: 5409: 5399: 5389: 5357: 5351: 5350: 5332: 5308: 5302: 5301: 5273: 5267: 5266: 5256: 5227:G-Quadruplex DNA 5222: 5216: 5215: 5205: 5173: 5167: 5166: 5149:(10): 997–1013. 5140: 5131: 5125: 5124: 5084: 5078: 5077: 5067: 5027: 5021: 5020: 5000: 4994: 4993: 4974:10.1038/330495a0 4949: 4943: 4942: 4932: 4915:(14): 4598–608. 4900: 4894: 4893: 4865: 4859: 4858: 4848: 4816: 4810: 4809: 4777: 4771: 4770: 4760: 4750: 4718: 4712: 4711: 4701: 4661: 4655: 4654: 4617: 4611: 4610: 4600: 4583:(22): 7698–713. 4568: 4562: 4561: 4551: 4519: 4513: 4512: 4495:(49): 16341–50. 4483: 4477: 4476: 4466: 4425: 4419: 4418: 4408: 4376: 4370: 4369: 4347: 4338: 4332: 4331: 4302: 4293: 4292: 4282: 4259:The FEBS Journal 4250: 4244: 4243: 4237: 4233: 4231: 4223: 4213: 4179: 4173: 4172: 4146: 4137: 4131: 4130: 4120: 4088: 4082: 4081: 4071: 4048:The EMBO Journal 4039: 4033: 4032: 4022: 3990: 3984: 3983: 3973: 3941: 3932: 3931: 3921: 3889: 3880: 3879: 3869: 3837: 3828: 3827: 3817: 3785: 3772: 3771: 3754:(3): 1109–1152. 3748:Chemical Reviews 3743: 3737: 3736: 3726: 3694: 3685: 3684: 3674: 3657:(9): 2863–2874. 3642: 3633: 3632: 3622: 3605:(6): 1293–1300. 3590: 3577: 3576: 3566: 3556: 3524: 3505: 3504: 3498: 3490: 3436: 3427: 3426: 3386: 3380: 3379: 3369: 3337: 3331: 3330: 3320: 3280: 3274: 3273: 3263: 3232:Nature Chemistry 3223: 3217: 3216: 3206: 3196: 3172: 3166: 3165: 3155: 3145: 3121: 3115: 3114: 3104: 3094: 3070: 3059: 3058: 3038: 3032: 3031: 3021: 2989: 2980: 2979: 2977: 2953: 2947: 2946: 2936: 2927:(46): 38117–20. 2912: 2906: 2905: 2895: 2885: 2853: 2847: 2846: 2836: 2804: 2798: 2797: 2787: 2755: 2749: 2748: 2738: 2706: 2697: 2696: 2686: 2654: 2648: 2647: 2637: 2605: 2599: 2598: 2588: 2578: 2546: 2540: 2539: 2529: 2497: 2491: 2490: 2480: 2470: 2446: 2440: 2439: 2429: 2419: 2389: 2383: 2382: 2346: 2340: 2339: 2329: 2319: 2287: 2281: 2280: 2270: 2238: 2232: 2231: 2221: 2197: 2191: 2190: 2180: 2148: 2142: 2141: 2113: 2107: 2106: 2096: 2072: 2066: 2065: 2055: 2045: 2013: 2007: 2006: 1996: 1964: 1958: 1957: 1947: 1915: 1909: 1908: 1872: 1866: 1865: 1855: 1822: 1816: 1815: 1805: 1774:Nature Chemistry 1765: 1759: 1758: 1722: 1716: 1715: 1705: 1695: 1663: 1657: 1656: 1636: 1630: 1629: 1619: 1587: 1581: 1580: 1570: 1538: 1532: 1531: 1521: 1489: 1483: 1482: 1472: 1440: 1434: 1433: 1405: 1399: 1398: 1369: 1363: 1362: 1342: 1329: 1328: 1318: 1286: 1273: 1272: 1253:10.1038/334364a0 1228: 1217: 1216: 1197:10.1038/342825a0 1172: 1163: 1162: 1134: 1123: 1114: 1113: 1103: 1071: 1065: 1064: 1054: 1044: 1012: 969:oligonucleotides 835:(FMR1) gene and 712:electron density 576:Promoter Regions 518:thymidine kinase 480:oxidative stress 147: 7285: 7284: 7280: 7279: 7278: 7276: 7275: 7274: 7250: 7249: 7220: 7200:Wayback Machine 7160: 7155: 7150: 7130:(23): 7515–22. 7111: 7030:Genome Research 6983:(18): 11593–8. 6940:(19): 5402–15. 6778:(38): 10563–5. 6765: 6763:Further reading 6760: 6748: 6747: 6738: 6737: 6717: 6695: 6691: 6644: 6640: 6619:(12): 2602–12. 6609: 6605: 6574: 6570: 6525: 6521: 6489: 6485: 6440: 6436: 6405:(12): 2178–85. 6391: 6387: 6332: 6328: 6289:(7409): 111–5. 6275: 6271: 6225: 6221: 6180:(47): E4530–9. 6165: 6161: 6115: 6111: 6066: 6062: 6031: 6027: 5988: 5984: 5971: 5970: 5966: 5929: 5925: 5888: 5884: 5839: 5835: 5782: 5778: 5731: 5727: 5674: 5670: 5620: 5616: 5570: 5566: 5537:(11): 1615–21. 5527: 5523: 5510: 5509: 5505: 5482:(14): 1653–68. 5468: 5464: 5417: 5413: 5358: 5354: 5309: 5305: 5274: 5270: 5245: 5223: 5219: 5174: 5170: 5138: 5132: 5128: 5085: 5081: 5028: 5024: 5001: 4997: 4960:(6147): 495–7. 4950: 4946: 4901: 4897: 4866: 4862: 4817: 4813: 4778: 4774: 4733:(18): 11593–8. 4719: 4715: 4662: 4658: 4618: 4614: 4569: 4565: 4534:(33): 10220–8. 4520: 4516: 4484: 4480: 4426: 4422: 4391:(18): 6070–80. 4377: 4373: 4345: 4339: 4335: 4303: 4296: 4265:(17): 3459–69. 4251: 4247: 4235: 4234: 4225: 4224: 4202: 4180: 4176: 4144: 4138: 4134: 4089: 4085: 4040: 4036: 3991: 3987: 3942: 3935: 3890: 3883: 3838: 3831: 3786: 3775: 3744: 3740: 3695: 3688: 3643: 3636: 3591: 3580: 3525: 3508: 3492: 3491: 3463: 3437: 3430: 3407:10.1038/ng.3662 3395:Nature Genetics 3387: 3383: 3338: 3334: 3281: 3277: 3224: 3220: 3187:(4): e1003468. 3177:"The G4 genome" 3173: 3169: 3122: 3118: 3071: 3062: 3039: 3035: 2990: 2983: 2954: 2950: 2913: 2909: 2854: 2850: 2813:Genome Research 2805: 2801: 2756: 2752: 2721:(25): 7854–60. 2707: 2700: 2655: 2651: 2606: 2602: 2561:(18): 11593–8. 2547: 2543: 2498: 2494: 2447: 2443: 2398: 2390: 2386: 2363:10.1038/nsmb982 2347: 2343: 2288: 2284: 2253:(14): 6229–37. 2239: 2235: 2198: 2194: 2149: 2145: 2124:(24): 7957–63. 2114: 2110: 2073: 2069: 2028:(1): e0146174. 2014: 2010: 1965: 1961: 1930:(19): 5402–15. 1916: 1912: 1873: 1869: 1823: 1819: 1766: 1762: 1723: 1719: 1664: 1660: 1637: 1633: 1602:(18): 8627–37. 1588: 1584: 1539: 1535: 1490: 1486: 1461:10.1038/nrg3296 1441: 1437: 1406: 1402: 1370: 1366: 1343: 1332: 1295:Genome Research 1287: 1276: 1239:(6180): 364–6. 1229: 1220: 1183:(6251): 825–9. 1173: 1166: 1151: 1132: 1124: 1117: 1072: 1068: 1027:(7): e1000861. 1013: 1009: 1005: 946: 938:heterochromatin 934:DNA methylation 900: 896: 892: 888: 884: 880: 876: 872: 864: 860: 820: 795: 786: 778: 753:nucleotide base 750: 746: 742: 738: 734: 730: 726: 720: 660: 647:porphyrin rings 643: 611:promoter region 578: 558: 553: 526: 497:ChIP-sequencing 467: 446:ChIP-sequencing 438:ChIP-sequencing 429: 395: 323:proto-oncogenes 286: 233: 175: 155: 139: 95: 17: 12: 11: 5: 7283: 7273: 7272: 7267: 7262: 7248: 7247: 7242: 7237: 7232: 7227: 7219: 7216: 7215: 7214: 7208: 7203: 7190: 7184: 7179: 7173: 7167: 7159: 7156: 7154: 7153:External links 7151: 7149: 7148: 7119: 7117:on 2007-09-30. 7109: 7094: 7076:(22): 7800–5. 7064: 7021: 6968: 6925: 6882: 6854:(9): 2908–16. 6839: 6811:(8): 1250–63. 6796: 6766: 6764: 6761: 6759: 6758: 6749:|journal= 6715: 6689: 6638: 6603: 6584:(8): 1675–80. 6568: 6519: 6500:(2): 564–568. 6483: 6434: 6385: 6346:(11): 4221–6. 6326: 6269: 6219: 6159: 6109: 6060: 6041:(6): 397–400. 6025: 5998:(4): 817–822. 5982: 5964: 5923: 5882: 5853:(4): 489–499. 5833: 5776: 5745:(14): 9860–6. 5725: 5668: 5614: 5564: 5521: 5503: 5462: 5411: 5352: 5303: 5284:(4): 324–331. 5268: 5243: 5217: 5188:(2): 537–542. 5168: 5126: 5079: 5036:Bioinformatics 5022: 4995: 4944: 4895: 4860: 4811: 4792:(5): 2723–31. 4772: 4713: 4656: 4612: 4563: 4514: 4478: 4420: 4371: 4333: 4314:(16): 5671–9. 4294: 4245: 4236:|journal= 4201:978-0471142706 4200: 4174: 4132: 4103:(3): 832–845. 4083: 4034: 3985: 3933: 3881: 3829: 3773: 3738: 3709:(2): 430–438. 3686: 3634: 3578: 3506: 3461: 3428: 3381: 3332: 3275: 3218: 3167: 3116: 3060: 3033: 3004:(1): 172–183. 2981: 2948: 2907: 2848: 2799: 2770:(9): 2908–16. 2750: 2698: 2649: 2600: 2541: 2512:(5): 1167–72. 2492: 2441: 2396: 2384: 2357:(10): 847–54. 2341: 2302:(15): 8572–7. 2282: 2233: 2192: 2143: 2108: 2067: 2008: 1959: 1910: 1867: 1838:(3): 301–310. 1817: 1760: 1733:(6): 899–908. 1717: 1678:(12): 2013–8. 1658: 1631: 1582: 1533: 1484: 1455:(11): 770–80. 1435: 1400: 1364: 1330: 1301:(5): 644–655. 1274: 1218: 1164: 1149: 1115: 1066: 1006: 1004: 1001: 989:aromatic rings 945: 942: 898: 894: 890: 886: 882: 878: 874: 870: 862: 858: 819: 816: 794: 791: 785: 782: 777: 774: 748: 744: 740: 736: 732: 728: 724: 719: 716: 659: 656: 642: 639: 577: 574: 557: 554: 552: 549: 525: 522: 510:carcinogenesis 466: 463: 428: 425: 394: 391: 387:non-coding DNA 375:downregulation 294:proto-oncogene 285: 282: 232: 229: 191:thermodynamics 174: 171: 154: 151: 94: 91: 75:intramolecular 44:guanine tetrad 15: 9: 6: 4: 3: 2: 7282: 7271: 7268: 7266: 7263: 7261: 7258: 7257: 7255: 7245: 7243: 7240: 7238: 7235: 7233: 7231: 7228: 7225: 7222: 7221: 7212: 7209: 7207: 7204: 7201: 7197: 7194: 7191: 7188: 7185: 7183: 7180: 7177: 7174: 7171: 7168: 7165: 7162: 7161: 7145: 7141: 7137: 7133: 7129: 7125: 7120: 7116: 7112: 7106: 7102: 7101: 7095: 7091: 7087: 7083: 7079: 7075: 7071: 7065: 7061: 7057: 7052: 7047: 7043: 7039: 7036:(5): 644–55. 7035: 7031: 7027: 7022: 7018: 7014: 7009: 7004: 6999: 6994: 6990: 6986: 6982: 6978: 6974: 6969: 6965: 6961: 6956: 6951: 6947: 6943: 6939: 6935: 6931: 6926: 6922: 6918: 6913: 6908: 6904: 6900: 6897:(9): 2901–7. 6896: 6892: 6888: 6883: 6879: 6875: 6870: 6865: 6861: 6857: 6853: 6849: 6845: 6840: 6836: 6832: 6827: 6822: 6818: 6814: 6810: 6806: 6802: 6797: 6793: 6789: 6785: 6781: 6777: 6773: 6768: 6767: 6754: 6742: 6734: 6730: 6726: 6722: 6718: 6716:9783110470734 6712: 6708: 6704: 6700: 6693: 6685: 6681: 6676: 6671: 6666: 6661: 6658:(8): 4653–9. 6657: 6653: 6649: 6642: 6634: 6630: 6626: 6622: 6618: 6614: 6607: 6599: 6595: 6591: 6587: 6583: 6579: 6572: 6564: 6560: 6555: 6550: 6546: 6542: 6538: 6534: 6530: 6523: 6515: 6511: 6507: 6503: 6499: 6495: 6487: 6479: 6475: 6470: 6465: 6461: 6457: 6453: 6449: 6445: 6438: 6430: 6426: 6421: 6416: 6412: 6408: 6404: 6400: 6396: 6389: 6381: 6377: 6372: 6367: 6362: 6357: 6353: 6349: 6345: 6341: 6337: 6330: 6322: 6318: 6313: 6308: 6304: 6300: 6296: 6292: 6288: 6284: 6280: 6273: 6265: 6261: 6256: 6251: 6247: 6243: 6239: 6235: 6231: 6223: 6215: 6211: 6206: 6201: 6196: 6191: 6187: 6183: 6179: 6175: 6171: 6163: 6155: 6151: 6146: 6141: 6137: 6133: 6130:(2): 415–28. 6129: 6125: 6121: 6113: 6105: 6101: 6096: 6091: 6087: 6083: 6080:(5): 515–23. 6079: 6075: 6071: 6064: 6056: 6052: 6048: 6044: 6040: 6036: 6029: 6021: 6017: 6013: 6009: 6005: 6001: 5997: 5993: 5986: 5978: 5974: 5968: 5960: 5956: 5951: 5946: 5942: 5938: 5934: 5927: 5919: 5915: 5910: 5905: 5901: 5897: 5893: 5886: 5878: 5874: 5870: 5866: 5861: 5856: 5852: 5848: 5844: 5837: 5829: 5825: 5820: 5815: 5811: 5807: 5803: 5799: 5795: 5791: 5787: 5780: 5772: 5768: 5763: 5758: 5753: 5748: 5744: 5740: 5736: 5729: 5721: 5717: 5712: 5707: 5703: 5699: 5695: 5691: 5687: 5683: 5679: 5672: 5664: 5660: 5655: 5650: 5646: 5642: 5639:(3): 345–53. 5638: 5634: 5630: 5626: 5618: 5610: 5606: 5601: 5596: 5592: 5588: 5584: 5580: 5576: 5568: 5560: 5556: 5552: 5548: 5544: 5540: 5536: 5532: 5525: 5517: 5513: 5507: 5499: 5495: 5490: 5485: 5481: 5477: 5473: 5466: 5458: 5454: 5450: 5446: 5442: 5438: 5434: 5430: 5426: 5422: 5415: 5407: 5403: 5398: 5393: 5388: 5383: 5379: 5375: 5371: 5367: 5363: 5356: 5348: 5344: 5340: 5336: 5331: 5326: 5322: 5318: 5314: 5307: 5299: 5295: 5291: 5287: 5283: 5279: 5272: 5264: 5260: 5255: 5250: 5246: 5244:9781588299505 5240: 5236: 5232: 5228: 5221: 5213: 5209: 5204: 5199: 5195: 5191: 5187: 5183: 5179: 5172: 5164: 5160: 5156: 5152: 5148: 5144: 5137: 5130: 5122: 5118: 5114: 5110: 5106: 5102: 5098: 5094: 5090: 5083: 5075: 5071: 5066: 5061: 5057: 5053: 5049: 5045: 5041: 5037: 5033: 5026: 5018: 5014: 5011:(4): 207–15. 5010: 5006: 4999: 4991: 4987: 4983: 4979: 4975: 4971: 4967: 4963: 4959: 4955: 4948: 4940: 4936: 4931: 4926: 4922: 4918: 4914: 4910: 4906: 4899: 4891: 4887: 4883: 4879: 4875: 4871: 4864: 4856: 4852: 4847: 4842: 4838: 4834: 4831:(9): 2901–7. 4830: 4826: 4822: 4815: 4807: 4803: 4799: 4795: 4791: 4787: 4783: 4776: 4768: 4764: 4759: 4754: 4749: 4744: 4740: 4736: 4732: 4728: 4724: 4717: 4709: 4705: 4700: 4695: 4691: 4687: 4683: 4679: 4675: 4671: 4667: 4660: 4652: 4648: 4644: 4640: 4636: 4632: 4628: 4624: 4616: 4608: 4604: 4599: 4594: 4590: 4586: 4582: 4578: 4574: 4567: 4559: 4555: 4550: 4545: 4541: 4537: 4533: 4529: 4525: 4518: 4510: 4506: 4502: 4498: 4494: 4490: 4482: 4474: 4470: 4465: 4460: 4456: 4452: 4448: 4444: 4440: 4436: 4432: 4424: 4416: 4412: 4407: 4402: 4398: 4394: 4390: 4386: 4382: 4375: 4367: 4363: 4359: 4355: 4351: 4344: 4337: 4329: 4325: 4321: 4317: 4313: 4309: 4301: 4299: 4290: 4286: 4281: 4276: 4272: 4268: 4264: 4260: 4256: 4249: 4241: 4229: 4221: 4217: 4212: 4207: 4203: 4197: 4193: 4189: 4185: 4178: 4170: 4166: 4162: 4158: 4154: 4150: 4143: 4136: 4128: 4124: 4119: 4114: 4110: 4106: 4102: 4098: 4094: 4087: 4079: 4075: 4070: 4065: 4061: 4057: 4053: 4049: 4045: 4038: 4030: 4026: 4021: 4016: 4012: 4008: 4004: 4000: 3996: 3989: 3981: 3977: 3972: 3967: 3963: 3959: 3955: 3951: 3947: 3940: 3938: 3929: 3925: 3920: 3915: 3911: 3907: 3903: 3899: 3895: 3888: 3886: 3877: 3873: 3868: 3863: 3859: 3855: 3851: 3847: 3843: 3836: 3834: 3825: 3821: 3816: 3811: 3807: 3803: 3799: 3795: 3791: 3784: 3782: 3780: 3778: 3769: 3765: 3761: 3757: 3753: 3749: 3742: 3734: 3730: 3725: 3720: 3716: 3712: 3708: 3704: 3700: 3693: 3691: 3682: 3678: 3673: 3668: 3664: 3660: 3656: 3652: 3648: 3641: 3639: 3630: 3626: 3621: 3616: 3612: 3608: 3604: 3600: 3596: 3589: 3587: 3585: 3583: 3574: 3570: 3565: 3560: 3555: 3550: 3546: 3542: 3538: 3534: 3530: 3523: 3521: 3519: 3517: 3515: 3513: 3511: 3502: 3496: 3488: 3484: 3480: 3476: 3472: 3468: 3464: 3458: 3454: 3450: 3446: 3442: 3435: 3433: 3424: 3420: 3416: 3412: 3408: 3404: 3400: 3396: 3392: 3385: 3377: 3373: 3368: 3363: 3359: 3355: 3351: 3347: 3343: 3336: 3328: 3324: 3319: 3314: 3310: 3306: 3302: 3298: 3294: 3290: 3286: 3279: 3271: 3267: 3262: 3257: 3253: 3249: 3245: 3241: 3237: 3233: 3229: 3222: 3214: 3210: 3205: 3200: 3195: 3190: 3186: 3182: 3181:PLOS Genetics 3178: 3171: 3163: 3159: 3154: 3149: 3144: 3139: 3135: 3131: 3127: 3120: 3112: 3108: 3103: 3098: 3093: 3088: 3084: 3080: 3076: 3069: 3067: 3065: 3056: 3052: 3049:(44): 28–30. 3048: 3044: 3037: 3029: 3025: 3020: 3015: 3011: 3007: 3003: 2999: 2995: 2988: 2986: 2976: 2971: 2967: 2963: 2959: 2952: 2944: 2940: 2935: 2930: 2926: 2922: 2918: 2911: 2903: 2899: 2894: 2889: 2884: 2879: 2875: 2871: 2868:(1): e30189. 2867: 2863: 2859: 2852: 2844: 2840: 2835: 2830: 2826: 2822: 2819:(5): 644–55. 2818: 2814: 2810: 2803: 2795: 2791: 2786: 2781: 2777: 2773: 2769: 2765: 2761: 2754: 2746: 2742: 2737: 2732: 2728: 2724: 2720: 2716: 2712: 2705: 2703: 2694: 2690: 2685: 2680: 2676: 2672: 2669:(4): 1096–8. 2668: 2664: 2660: 2653: 2645: 2641: 2636: 2631: 2627: 2623: 2620:(2): 406–13. 2619: 2615: 2611: 2604: 2596: 2592: 2587: 2582: 2577: 2572: 2568: 2564: 2560: 2556: 2552: 2545: 2537: 2533: 2528: 2523: 2519: 2515: 2511: 2507: 2503: 2496: 2488: 2484: 2479: 2474: 2469: 2464: 2460: 2456: 2452: 2445: 2437: 2433: 2428: 2423: 2418: 2413: 2409: 2405: 2401: 2399: 2388: 2380: 2376: 2372: 2368: 2364: 2360: 2356: 2352: 2345: 2337: 2333: 2328: 2323: 2318: 2313: 2309: 2305: 2301: 2297: 2293: 2286: 2278: 2274: 2269: 2264: 2260: 2256: 2252: 2248: 2244: 2237: 2229: 2225: 2220: 2215: 2212:(4): 1984–9. 2211: 2207: 2203: 2196: 2188: 2184: 2179: 2174: 2170: 2166: 2163:(1): 327–38. 2162: 2158: 2154: 2147: 2139: 2135: 2131: 2127: 2123: 2119: 2112: 2104: 2100: 2095: 2090: 2086: 2082: 2078: 2071: 2063: 2059: 2054: 2049: 2044: 2039: 2035: 2031: 2027: 2023: 2019: 2012: 2004: 2000: 1995: 1990: 1986: 1982: 1978: 1974: 1970: 1963: 1955: 1951: 1946: 1941: 1937: 1933: 1929: 1925: 1921: 1914: 1906: 1902: 1898: 1894: 1890: 1886: 1882: 1878: 1871: 1863: 1859: 1854: 1849: 1845: 1841: 1837: 1833: 1829: 1821: 1813: 1809: 1804: 1799: 1795: 1791: 1787: 1783: 1779: 1775: 1771: 1764: 1756: 1752: 1748: 1744: 1740: 1736: 1732: 1728: 1721: 1713: 1709: 1704: 1699: 1694: 1689: 1685: 1681: 1677: 1673: 1669: 1662: 1654: 1650: 1647:(44): 28–30. 1646: 1642: 1635: 1627: 1623: 1618: 1613: 1609: 1605: 1601: 1597: 1593: 1586: 1578: 1574: 1569: 1564: 1560: 1556: 1552: 1548: 1544: 1537: 1529: 1525: 1520: 1515: 1511: 1507: 1503: 1499: 1495: 1488: 1480: 1476: 1471: 1466: 1462: 1458: 1454: 1450: 1446: 1439: 1431: 1427: 1423: 1419: 1416:(4): 136–42. 1415: 1411: 1404: 1396: 1392: 1388: 1384: 1380: 1376: 1368: 1360: 1356: 1353:(22): 12–17. 1352: 1348: 1341: 1339: 1337: 1335: 1326: 1322: 1317: 1312: 1308: 1304: 1300: 1296: 1292: 1285: 1283: 1281: 1279: 1270: 1266: 1262: 1258: 1254: 1250: 1246: 1242: 1238: 1234: 1227: 1225: 1223: 1214: 1210: 1206: 1202: 1198: 1194: 1190: 1186: 1182: 1178: 1171: 1169: 1160: 1156: 1152: 1146: 1142: 1138: 1131: 1130: 1122: 1120: 1111: 1107: 1102: 1097: 1093: 1092:10.3791/55496 1089: 1085: 1081: 1077: 1070: 1062: 1058: 1053: 1048: 1043: 1038: 1034: 1030: 1026: 1022: 1018: 1011: 1007: 1000: 996: 994: 990: 986: 981: 979: 975: 970: 965: 962: 958: 956: 951: 941: 939: 935: 931: 927: 923: 919: 915: 910: 908: 904: 868: 856: 852: 849: 845: 840: 838: 834: 830: 826: 815: 813: 809: 805: 801: 790: 781: 773: 769: 766: 762: 758: 754: 715: 713: 707: 705: 700: 698: 693: 692:nucleic acids 688: 682: 680: 676: 671: 669: 665: 655: 651: 648: 638: 634: 631: 626: 622: 620: 615: 612: 606: 602: 600: 594: 591: 587: 583: 573: 571: 567: 563: 548: 545: 540: 536: 532: 521: 519: 515: 511: 505: 504: 500: 498: 493: 489: 485: 481: 477: 473: 462: 460: 456: 452: 447: 443: 439: 434: 424: 422: 421: 416: 412: 408: 404: 400: 390: 388: 384: 383:transcription 380: 376: 372: 368: 364: 360: 356: 353: 349: 345: 343: 339: 335: 331: 327: 324: 320: 316: 313: 310: 306: 302: 298: 295: 291: 281: 279: 275: 271: 268: 264: 261: 257: 253: 249: 248: 243: 242: 237: 228: 225: 219: 216: 210: 208: 204: 200: 196: 192: 188: 184: 180: 170: 167: 163: 161: 146: 142: 135: 131: 129: 124: 120: 116: 112: 108: 104: 100: 90: 88: 84: 80: 76: 73:, and may be 72: 68: 64: 60: 56: 53:, especially 52: 47: 45: 41: 37: 33: 30: 21: 7260:G-quadruplex 7127: 7123: 7115:the original 7099: 7073: 7069: 7033: 7029: 6980: 6976: 6937: 6933: 6894: 6890: 6851: 6847: 6808: 6804: 6775: 6771: 6698: 6692: 6655: 6651: 6641: 6616: 6612: 6606: 6581: 6578:Biochemistry 6577: 6571: 6536: 6532: 6522: 6497: 6493: 6486: 6451: 6448:Biochemistry 6447: 6437: 6402: 6398: 6388: 6343: 6339: 6329: 6286: 6282: 6272: 6237: 6233: 6222: 6177: 6173: 6162: 6127: 6123: 6112: 6077: 6073: 6063: 6038: 6034: 6028: 5995: 5991: 5985: 5976: 5967: 5940: 5936: 5926: 5899: 5895: 5885: 5850: 5846: 5836: 5793: 5789: 5779: 5742: 5738: 5728: 5685: 5681: 5671: 5636: 5632: 5617: 5582: 5578: 5567: 5534: 5530: 5524: 5515: 5506: 5479: 5476:FEBS Letters 5475: 5465: 5424: 5421:Nano Letters 5420: 5414: 5369: 5365: 5355: 5323:(1): 74–78. 5320: 5317:FEBS Letters 5316: 5306: 5281: 5277: 5271: 5226: 5220: 5185: 5181: 5171: 5146: 5142: 5129: 5096: 5092: 5082: 5039: 5035: 5025: 5008: 5004: 4998: 4957: 4953: 4947: 4912: 4908: 4898: 4876:(9): 65–95. 4873: 4869: 4863: 4828: 4824: 4814: 4789: 4785: 4775: 4730: 4726: 4716: 4673: 4669: 4659: 4626: 4623:Biochemistry 4622: 4615: 4580: 4576: 4566: 4531: 4527: 4517: 4492: 4489:Biochemistry 4488: 4481: 4441:(1): 11541. 4438: 4434: 4423: 4388: 4384: 4374: 4349: 4336: 4311: 4307: 4262: 4258: 4248: 4183: 4177: 4152: 4148: 4135: 4100: 4096: 4086: 4051: 4047: 4037: 4002: 3998: 3988: 3953: 3949: 3901: 3897: 3849: 3845: 3797: 3793: 3751: 3747: 3741: 3706: 3702: 3654: 3650: 3602: 3598: 3536: 3532: 3444: 3398: 3394: 3384: 3349: 3345: 3335: 3292: 3288: 3278: 3238:(3): 182–6. 3235: 3231: 3221: 3184: 3180: 3170: 3133: 3129: 3119: 3082: 3078: 3046: 3042: 3036: 3001: 2997: 2965: 2961: 2951: 2924: 2920: 2910: 2865: 2861: 2851: 2816: 2812: 2802: 2767: 2763: 2753: 2718: 2715:Biochemistry 2714: 2666: 2662: 2652: 2617: 2613: 2603: 2558: 2554: 2544: 2509: 2505: 2495: 2461:(14): 7381. 2458: 2454: 2444: 2407: 2403: 2395: 2387: 2354: 2350: 2344: 2299: 2295: 2285: 2250: 2246: 2236: 2209: 2205: 2195: 2160: 2156: 2146: 2121: 2117: 2111: 2087:(25): 22–9. 2084: 2080: 2070: 2025: 2021: 2011: 1976: 1972: 1962: 1927: 1923: 1913: 1883:(4): 621–8. 1880: 1876: 1870: 1835: 1831: 1820: 1777: 1773: 1763: 1730: 1726: 1720: 1675: 1671: 1661: 1644: 1640: 1634: 1599: 1595: 1585: 1550: 1546: 1536: 1501: 1497: 1487: 1452: 1448: 1438: 1413: 1409: 1403: 1378: 1374: 1367: 1350: 1346: 1298: 1294: 1236: 1232: 1180: 1176: 1128: 1083: 1079: 1069: 1024: 1020: 1010: 997: 982: 966: 959: 947: 911: 841: 821: 796: 787: 779: 770: 721: 708: 703: 701: 683: 679:telomestatin 672: 661: 652: 644: 641:Therapeutics 635: 627: 623: 619:angiogenesis 616: 607: 603: 595: 589: 579: 570:cell's death 559: 531:8-oxoguanine 527: 506: 502: 501: 468: 430: 418: 396: 371:upregulation 366: 358: 346: 287: 278:telomestatin 245: 239: 234: 220: 211: 176: 168: 164: 156: 127: 122: 114: 110: 96: 87:antiparallel 48: 29:G-quadruplex 28: 26: 7166:{NAB group} 5099:: 115–118. 3800:: 207–219. 3445:The Nucleus 1979:(1): 3–10. 855:presynaptic 755:(including 363:prokaryotes 252:vertebrates 79:bimolecular 7254:Categories 5977:Gene Cards 2968:(8): 253. 1003:References 918:elongation 761:algorithms 675:porphyrins 562:eukaryotic 514:epigenetic 484:tautomeric 270:telomerase 258:, TEM and 224:telomerase 203:chromosome 119:Aaron Klug 7193:GRS_UTRdb 6805:Biochimie 6751:ignored ( 6741:cite book 5625:Rossor MN 5531:Neurology 5457:203638480 5093:Biochimie 5056:1367-4803 4676:: 11385. 4366:214472968 4238:ignored ( 4228:cite book 3495:cite book 3487:220631202 3471:1940-6029 3352:: 161–7. 978:SCID mice 907:ribosomes 903:nucleolin 851:cytoplasm 827:(ALS) or 765:eumetazoa 673:Cationic 582:telomeric 556:Telomeres 433:AP sites. 420:Neisseria 381:blocking 319:ubiquitin 236:Telomeric 215:Telomeres 183:chromatin 107:telomeric 55:potassium 40:Hoogsteen 7196:Archived 7176:Greglist 7144:24148836 7090:19435350 7060:16651665 7017:12195017 6964:17012276 6921:15914666 6878:15914667 6835:18331848 6792:21858307 6733:44981950 6725:29394031 6684:24371143 6633:24814531 6598:19173611 6563:23471001 6514:19099510 6478:21028906 6429:21971427 6380:22371589 6321:22859208 6264:24154603 6214:24170860 6154:24139042 6104:25188012 6020:31455523 5959:19097999 5918:14570712 5869:11719189 5828:24598541 5771:23423380 5720:23264878 5688:: 1016. 5663:23434116 5609:22840558 5559:45904851 5551:12058088 5498:25979174 5449:31577148 5406:25225404 5298:17967702 5263:20012416 5163:28755976 5121:47005625 5113:29885355 5074:30721922 5017:20656986 4939:18614607 4855:15914666 4806:22280460 4767:12195017 4708:26077929 4651:53093959 4643:30369235 4607:17984069 4558:17672459 4509:16331995 4473:28912501 4415:16239639 4328:21774525 4289:20670278 4220:22956454 4169:26840940 4127:19934257 4078:14633989 4029:18809583 3980:27994014 3928:31226203 3876:28936535 3824:31993111 3768:11848927 3733:11139613 3681:19385599 3629:24485507 3573:32404420 3479:32681486 3423:20967177 3415:27618450 3376:27239262 3327:29899445 3270:23422559 3213:23637633 3162:31575660 3111:28717007 3028:19033359 2962:Crystals 2943:16150737 2902:22272300 2862:PLOS ONE 2843:16651665 2794:15914667 2745:16784237 2693:16433524 2644:17169996 2595:12195017 2487:34299001 2436:29674319 2371:16142245 2336:11438689 2277:21441540 2228:26810457 2187:19858105 2138:16771510 2103:24584093 2062:26727593 2022:PLOS ONE 2003:22652626 1954:17012276 1905:43536134 1897:11405224 1862:22306580 1812:21107376 1755:37343642 1712:13947099 1626:26350216 1577:27185890 1528:17962308 1479:23032257 1430:10740289 1395:18767830 1325:16651665 1159:26860303 1110:28362374 1061:20676380 922:dendrite 848:neuronal 800:nanopore 697:Ď€-Ď€ bond 668:proteins 586:oncogene 566:helicase 393:Function 379:promoter 317:, human 312:β-globin 305:promoter 301:nuclease 290:telomere 241:in vitro 153:Topology 148:​) 111:in vitro 83:parallel 7051:1457047 6985:Bibcode 6955:1636468 6912:1140077 6869:1140081 6826:2585026 6675:3931028 6554:3627599 6469:2991413 6420:3242664 6371:3306674 6348:Bibcode 6312:4221572 6291:Bibcode 6255:4090945 6205:3839752 6182:Bibcode 6145:4098943 6095:4165481 6055:1301913 6012:1878973 5877:8203054 5819:4046618 5798:Bibcode 5762:3617286 5711:3527825 5690:Bibcode 5654:3591848 5600:3617405 5429:Bibcode 5397:4209999 5374:Bibcode 5347:1306129 5339:9755862 5278:Methods 5254:2797547 5212:9862977 5065:6748775 4990:4360764 4982:2825028 4962:Bibcode 4930:2504309 4890:7574496 4846:1140077 4735:Bibcode 4699:4468576 4678:Bibcode 4598:2190695 4549:2566970 4464:5599563 4443:Bibcode 4406:1266068 4350:bioRxiv 4280:2971675 4211:3463244 4118:2817463 4020:2593380 3971:5335514 3919:6895268 3867:5636683 3815:6974700 3672:2757002 3620:5576885 3564:7260947 3541:Bibcode 3367:4872678 3318:6261253 3297:Bibcode 3261:3622242 3240:Bibcode 3204:3630100 3153:6879327 3102:5602382 3019:2615625 2893:3260238 2870:Bibcode 2834:1457047 2785:1140081 2736:2195898 2684:2556172 2635:1802602 2563:Bibcode 2536:9469822 2478:8306923 2427:6005428 2379:6079323 2304:Bibcode 2268:3152327 2178:2800236 2053:4699641 2030:Bibcode 1994:3701776 1973:Methods 1945:1636468 1853:3433707 1803:3119466 1782:Bibcode 1747:3690664 1680:Bibcode 1617:4605312 1568:4987949 1519:2238983 1470:3725559 1316:1457047 1269:4351855 1261:3393228 1241:Bibcode 1213:4357161 1205:2601741 1185:Bibcode 1101:5409278 1086:(121). 1052:2908698 1029:Bibcode 985:ligands 955:C9orf72 950:ligands 853:and at 844:C9orf72 757:guanine 664:ligands 490:enzyme 472:Guanine 367:E. coli 359:in vivo 309:chicken 274:cancers 247:in vivo 207:hairpin 187:histone 160:meiosis 128:in vivo 123:in vivo 115:in vivo 99:guanine 93:History 36:guanine 7142:  7107:  7088:  7058:  7048:  7015:  7008:129314 7005:  6962:  6952:  6919:  6909:  6876:  6866:  6833:  6823:  6790:  6731:  6723:  6713:  6682:  6672:  6631:  6596:  6561:  6551:  6512:  6476:  6466:  6427:  6417:  6378:  6368:  6319:  6309:  6283:Nature 6262:  6252:  6212:  6202:  6152:  6142:  6124:Neuron 6102:  6092:  6053:  6018:  6010:  5957:  5916:  5875:  5867:  5826:  5816:  5790:Nature 5769:  5759:  5718:  5708:  5661:  5651:  5607:  5597:  5557:  5549:  5496:  5455:  5447:  5404:  5394:  5345:  5337:  5296:  5261:  5251:  5241:  5210:  5203:148212 5200:  5161:  5119:  5111:  5072:  5062:  5054:  5015:  4988:  4980:  4954:Nature 4937:  4927:  4888:  4853:  4843:  4804:  4765:  4758:129314 4755:  4706:  4696:  4649:  4641:  4605:  4595:  4556:  4546:  4507:  4471:  4461:  4413:  4403:  4364:  4326:  4287:  4277:  4218:  4208:  4198:  4167:  4125:  4115:  4076:  4069:291836 4066:  4027:  4017:  3978:  3968:  3926:  3916:  3874:  3864:  3822:  3812:  3766:  3731:  3721:  3679:  3669:  3627:  3617:  3571:  3561:  3485:  3477:  3469:  3459:  3421:  3413:  3374:  3364:  3325:  3315:  3289:Nature 3268:  3258:  3211:  3201:  3160:  3150:  3109:  3099:  3026:  3016:  2941:  2900:  2890:  2841:  2831:  2792:  2782:  2743:  2733:  2691:  2681:  2642:  2632:  2593:  2586:129314 2583:  2534:  2527:147388 2524:  2485:  2475:  2434:  2424:  2377:  2369:  2334:  2324:  2275:  2265:  2226:  2185:  2175:  2136:  2101:  2060:  2050:  2001:  1991:  1952:  1942:  1903:  1895:  1860:  1850:  1810:  1800:  1753:  1745:  1710:  1703:221115 1700:  1624:  1614:  1575:  1565:  1526:  1516:  1477:  1467:  1428:  1393:  1323:  1313:  1267:  1259:  1233:Nature 1211:  1203:  1177:Nature 1157:  1147:  1108:  1098:  1059:  1049:  926:autism 867:intron 704:c-Myc. 630:kinase 551:Cancer 355:genome 348:Genome 267:enzyme 179:genome 69:, and 51:cation 7187:GRSDB 6729:S2CID 6016:S2CID 5873:S2CID 5555:S2CID 5453:S2CID 5343:S2CID 5139:(PDF) 5117:S2CID 4986:S2CID 4647:S2CID 4362:S2CID 4346:(PDF) 4145:(PDF) 3956:(6). 3724:29662 3483:S2CID 3419:S2CID 2375:S2CID 2327:37477 1901:S2CID 1751:S2CID 1265:S2CID 1209:S2CID 1133:(PDF) 687:BCL-2 590:c-Myc 411:DHX36 352:human 342:N-ras 338:H-ras 330:bcl-2 326:c-kit 297:c-myc 260:X-ray 7140:PMID 7105:ISBN 7086:PMID 7056:PMID 7013:PMID 6960:PMID 6917:PMID 6874:PMID 6831:PMID 6788:PMID 6753:help 6721:PMID 6711:ISBN 6680:PMID 6629:PMID 6594:PMID 6559:PMID 6510:PMID 6474:PMID 6425:PMID 6376:PMID 6317:PMID 6260:PMID 6210:PMID 6150:PMID 6100:PMID 6051:PMID 6008:PMID 5992:Cell 5955:PMID 5914:PMID 5865:PMID 5847:Cell 5824:PMID 5767:PMID 5716:PMID 5659:PMID 5605:PMID 5547:PMID 5494:PMID 5445:PMID 5402:PMID 5335:PMID 5294:PMID 5259:PMID 5239:ISBN 5208:PMID 5159:PMID 5109:PMID 5070:PMID 5052:ISSN 5013:PMID 4978:PMID 4935:PMID 4886:PMID 4851:PMID 4802:PMID 4763:PMID 4704:PMID 4639:PMID 4603:PMID 4554:PMID 4505:PMID 4469:PMID 4411:PMID 4324:PMID 4285:PMID 4240:help 4216:PMID 4196:ISBN 4165:PMID 4123:PMID 4074:PMID 4025:PMID 3976:PMID 3924:PMID 3872:PMID 3820:PMID 3764:PMID 3729:PMID 3677:PMID 3625:PMID 3569:PMID 3501:link 3475:PMID 3467:ISSN 3457:ISBN 3411:PMID 3372:PMID 3323:PMID 3266:PMID 3209:PMID 3158:PMID 3107:PMID 3024:PMID 2939:PMID 2898:PMID 2839:PMID 2790:PMID 2741:PMID 2689:PMID 2640:PMID 2591:PMID 2532:PMID 2483:PMID 2432:PMID 2367:PMID 2332:PMID 2273:PMID 2224:PMID 2183:PMID 2134:PMID 2099:PMID 2058:PMID 1999:PMID 1950:PMID 1893:PMID 1858:PMID 1808:PMID 1743:PMID 1727:Cell 1708:PMID 1622:PMID 1573:PMID 1524:PMID 1475:PMID 1426:PMID 1391:PMID 1321:PMID 1257:PMID 1201:PMID 1155:PMID 1145:ISBN 1106:PMID 1057:PMID 930:exon 810:and 539:OGG1 535:OGG1 492:OGG1 405:and 340:and 334:VEGF 315:gene 145:2HY9 117:” - 7270:RNA 7265:DNA 7132:doi 7078:doi 7074:131 7046:PMC 7038:doi 7003:PMC 6993:doi 6950:PMC 6942:doi 6907:PMC 6899:doi 6864:PMC 6856:doi 6821:PMC 6813:doi 6780:doi 6703:doi 6670:PMC 6660:doi 6656:289 6621:doi 6586:doi 6549:PMC 6541:doi 6502:doi 6464:PMC 6456:doi 6415:PMC 6407:doi 6366:PMC 6356:doi 6344:109 6307:PMC 6299:doi 6287:488 6250:PMC 6242:doi 6200:PMC 6190:doi 6178:110 6140:PMC 6132:doi 6090:PMC 6082:doi 6043:doi 6000:doi 5945:doi 5941:284 5904:doi 5855:doi 5851:107 5814:PMC 5806:doi 5794:507 5757:PMC 5747:doi 5743:288 5706:PMC 5698:doi 5649:PMC 5641:doi 5595:PMC 5587:doi 5539:doi 5484:doi 5480:589 5437:doi 5392:PMC 5382:doi 5370:111 5325:doi 5321:435 5286:doi 5249:PMC 5231:doi 5198:PMC 5190:doi 5151:doi 5101:doi 5097:151 5060:PMC 5044:doi 4970:doi 4958:330 4925:PMC 4917:doi 4878:doi 4841:PMC 4833:doi 4794:doi 4790:134 4753:PMC 4743:doi 4694:PMC 4686:doi 4631:doi 4593:PMC 4585:doi 4544:PMC 4536:doi 4532:129 4497:doi 4459:PMC 4451:doi 4401:PMC 4393:doi 4354:doi 4316:doi 4275:PMC 4267:doi 4263:277 4206:PMC 4188:doi 4157:doi 4113:PMC 4105:doi 4064:PMC 4056:doi 4015:PMC 4007:doi 3966:PMC 3958:doi 3914:PMC 3906:doi 3862:PMC 3854:doi 3810:PMC 3802:doi 3756:doi 3719:PMC 3711:doi 3667:PMC 3659:doi 3615:PMC 3607:doi 3559:PMC 3549:doi 3537:117 3449:doi 3403:doi 3362:PMC 3354:doi 3313:PMC 3305:doi 3293:558 3256:PMC 3248:doi 3199:PMC 3189:doi 3148:PMC 3138:doi 3134:294 3097:PMC 3087:doi 3083:292 3051:doi 3014:PMC 3006:doi 2970:doi 2929:doi 2925:280 2888:PMC 2878:doi 2829:PMC 2821:doi 2780:PMC 2772:doi 2731:PMC 2723:doi 2679:PMC 2671:doi 2667:128 2630:PMC 2622:doi 2581:PMC 2571:doi 2522:PMC 2514:doi 2473:PMC 2463:doi 2422:PMC 2412:doi 2408:293 2359:doi 2322:PMC 2312:doi 2263:PMC 2255:doi 2214:doi 2173:PMC 2165:doi 2126:doi 2122:128 2089:doi 2048:PMC 2038:doi 1989:PMC 1981:doi 1940:PMC 1932:doi 1885:doi 1881:382 1848:PMC 1840:doi 1798:PMC 1790:doi 1735:doi 1698:PMC 1688:doi 1649:doi 1612:PMC 1604:doi 1563:PMC 1555:doi 1514:PMC 1506:doi 1465:PMC 1457:doi 1418:doi 1383:doi 1355:doi 1311:PMC 1303:doi 1249:doi 1237:334 1193:doi 1181:342 1137:doi 1096:PMC 1088:doi 1084:121 1047:PMC 1037:doi 745:1-7 737:1-7 729:1-7 723:d(G 403:WRN 373:or 256:NMR 193:of 141:PDB 103:DNA 85:or 71:PNA 67:LNA 63:RNA 59:DNA 7256:: 7138:. 7128:21 7126:. 7084:. 7072:. 7054:. 7044:. 7034:16 7032:. 7028:. 7011:. 7001:. 6991:. 6981:99 6979:. 6975:. 6958:. 6948:. 6938:34 6936:. 6932:. 6915:. 6905:. 6895:33 6893:. 6889:. 6872:. 6862:. 6852:33 6850:. 6846:. 6829:. 6819:. 6809:90 6807:. 6803:. 6786:. 6776:47 6774:. 6745:: 6743:}} 6739:{{ 6727:. 6719:. 6709:. 6678:. 6668:. 6654:. 6650:. 6627:. 6617:24 6615:. 6592:. 6582:48 6580:. 6557:. 6547:. 6537:41 6535:. 6531:. 6508:. 6498:52 6496:. 6472:. 6462:. 6452:49 6450:. 6446:. 6423:. 6413:. 6403:19 6401:. 6397:. 6374:. 6364:. 6354:. 6342:. 6338:. 6315:. 6305:. 6297:. 6285:. 6281:. 6258:. 6248:. 6236:. 6232:. 6208:. 6198:. 6188:. 6176:. 6172:. 6148:. 6138:. 6128:80 6126:. 6122:. 6098:. 6088:. 6078:27 6076:. 6072:. 6049:. 6037:. 6014:. 6006:. 5996:66 5994:. 5975:. 5953:. 5939:. 5935:. 5912:. 5900:12 5898:. 5894:. 5871:. 5863:. 5849:. 5845:. 5822:. 5812:. 5804:. 5792:. 5788:. 5765:. 5755:. 5741:. 5737:. 5714:. 5704:. 5696:. 5684:. 5680:. 5657:. 5647:. 5637:92 5635:. 5631:. 5603:. 5593:. 5583:33 5581:. 5577:. 5553:. 5545:. 5535:58 5533:. 5514:. 5492:. 5478:. 5474:. 5451:. 5443:. 5435:. 5425:19 5423:. 5400:. 5390:. 5380:. 5368:. 5364:. 5341:. 5333:. 5319:. 5315:. 5292:. 5282:43 5280:. 5257:. 5247:. 5237:. 5206:. 5196:. 5186:27 5184:. 5180:. 5157:. 5147:35 5145:. 5141:. 5115:. 5107:. 5095:. 5091:. 5068:. 5058:. 5050:. 5040:35 5038:. 5034:. 5007:. 4984:. 4976:. 4968:. 4956:. 4933:. 4923:. 4913:36 4911:. 4907:. 4884:. 4874:64 4872:. 4849:. 4839:. 4829:33 4827:. 4823:. 4800:. 4788:. 4784:. 4761:. 4751:. 4741:. 4731:99 4729:. 4725:. 4702:. 4692:. 4684:. 4672:. 4668:. 4645:. 4637:. 4627:57 4625:. 4601:. 4591:. 4581:35 4579:. 4575:. 4552:. 4542:. 4530:. 4526:. 4503:. 4493:44 4491:. 4467:. 4457:. 4449:. 4437:. 4433:. 4409:. 4399:. 4389:33 4387:. 4383:. 4360:. 4352:. 4348:. 4322:. 4312:54 4310:. 4297:^ 4283:. 4273:. 4261:. 4257:. 4232:: 4230:}} 4226:{{ 4214:. 4204:. 4194:. 4163:. 4153:59 4151:. 4147:. 4121:. 4111:. 4101:38 4099:. 4095:. 4072:. 4062:. 4052:22 4050:. 4046:. 4023:. 4013:. 4003:28 4001:. 3997:. 3974:. 3964:. 3954:37 3952:. 3948:. 3936:^ 3922:. 3912:. 3902:47 3900:. 3896:. 3884:^ 3870:. 3860:. 3850:15 3848:. 3844:. 3832:^ 3818:. 3808:. 3798:18 3796:. 3792:. 3776:^ 3762:. 3752:98 3750:. 3727:. 3717:. 3707:29 3705:. 3701:. 3689:^ 3675:. 3665:. 3655:52 3653:. 3649:. 3637:^ 3623:. 3613:. 3603:35 3601:. 3597:. 3581:^ 3567:. 3557:. 3547:. 3535:. 3531:. 3509:^ 3497:}} 3493:{{ 3481:. 3473:. 3465:. 3455:. 3443:. 3431:^ 3417:. 3409:. 3399:48 3397:. 3393:. 3370:. 3360:. 3350:14 3348:. 3344:. 3321:. 3311:. 3303:. 3291:. 3287:. 3264:. 3254:. 3246:. 3234:. 3230:. 3207:. 3197:. 3183:. 3179:. 3156:. 3146:. 3132:. 3128:. 3105:. 3095:. 3081:. 3077:. 3063:^ 3047:87 3045:. 3022:. 3012:. 3002:37 3000:. 2996:. 2984:^ 2964:. 2960:. 2937:. 2923:. 2919:. 2896:. 2886:. 2876:. 2864:. 2860:. 2837:. 2827:. 2817:16 2815:. 2811:. 2788:. 2778:. 2768:33 2766:. 2762:. 2739:. 2729:. 2719:45 2717:. 2713:. 2701:^ 2687:. 2677:. 2665:. 2661:. 2638:. 2628:. 2618:35 2616:. 2612:. 2589:. 2579:. 2569:. 2559:99 2557:. 2553:. 2530:. 2520:. 2510:26 2508:. 2504:. 2481:. 2471:. 2459:22 2457:. 2453:. 2430:. 2420:. 2406:. 2402:. 2373:. 2365:. 2355:12 2353:. 2330:. 2320:. 2310:. 2300:98 2298:. 2294:. 2271:. 2261:. 2251:39 2249:. 2245:. 2222:. 2210:88 2208:. 2204:. 2181:. 2171:. 2161:38 2159:. 2155:. 2132:. 2120:. 2097:. 2085:25 2083:. 2079:. 2056:. 2046:. 2036:. 2026:11 2024:. 2020:. 1997:. 1987:. 1977:57 1975:. 1971:. 1948:. 1938:. 1928:34 1926:. 1922:. 1899:. 1891:. 1879:. 1856:. 1846:. 1834:. 1830:. 1806:. 1796:. 1788:. 1776:. 1772:. 1749:. 1741:. 1731:51 1729:. 1706:. 1696:. 1686:. 1676:48 1674:. 1670:. 1645:87 1643:. 1620:. 1610:. 1600:43 1598:. 1594:. 1571:. 1561:. 1551:44 1549:. 1545:. 1522:. 1512:. 1502:36 1500:. 1496:. 1473:. 1463:. 1453:13 1451:. 1447:. 1424:. 1414:21 1412:. 1389:. 1379:51 1377:. 1351:85 1349:. 1333:^ 1319:. 1309:. 1299:16 1297:. 1293:. 1277:^ 1263:. 1255:. 1247:. 1235:. 1221:^ 1207:. 1199:. 1191:. 1179:. 1167:^ 1153:. 1143:. 1118:^ 1104:. 1094:. 1082:. 1078:. 1055:. 1045:. 1035:. 1023:. 1019:. 839:. 749:3+ 741:3+ 733:3+ 725:3+ 681:. 572:. 344:. 336:, 332:, 328:, 280:. 143:: 77:, 65:, 61:, 7146:. 7134:: 7092:. 7080:: 7062:. 7040:: 7019:. 6995:: 6987:: 6966:. 6944:: 6923:. 6901:: 6880:. 6858:: 6837:. 6815:: 6794:. 6782:: 6755:) 6735:. 6705:: 6686:. 6662:: 6635:. 6623:: 6600:. 6588:: 6565:. 6543:: 6516:. 6504:: 6480:. 6458:: 6431:. 6409:: 6382:. 6358:: 6350:: 6323:. 6301:: 6293:: 6266:. 6244:: 6238:5 6216:. 6192:: 6184:: 6156:. 6134:: 6106:. 6084:: 6057:. 6045:: 6039:1 6022:. 6002:: 5979:. 5961:. 5947:: 5920:. 5906:: 5879:. 5857:: 5830:. 5808:: 5800:: 5773:. 5749:: 5722:. 5700:: 5692:: 5686:2 5665:. 5643:: 5611:. 5589:: 5561:. 5541:: 5500:. 5486:: 5459:. 5439:: 5431:: 5408:. 5384:: 5376:: 5349:. 5327:: 5300:. 5288:: 5265:. 5233:: 5214:. 5192:: 5165:. 5153:: 5123:. 5103:: 5076:. 5046:: 5019:. 5009:7 4992:. 4972:: 4964:: 4941:. 4919:: 4892:. 4880:: 4857:. 4835:: 4808:. 4796:: 4769:. 4745:: 4737:: 4710:. 4688:: 4680:: 4674:5 4653:. 4633:: 4609:. 4587:: 4560:. 4538:: 4511:. 4499:: 4475:. 4453:: 4445:: 4439:7 4417:. 4395:: 4368:. 4356:: 4330:. 4318:: 4291:. 4269:: 4242:) 4222:. 4190:: 4171:. 4159:: 4129:. 4107:: 4080:. 4058:: 4031:. 4009:: 3982:. 3960:: 3930:. 3908:: 3878:. 3856:: 3826:. 3804:: 3770:. 3758:: 3735:. 3713:: 3683:. 3661:: 3631:. 3609:: 3575:. 3551:: 3543:: 3503:) 3489:. 3451:: 3425:. 3405:: 3378:. 3356:: 3329:. 3307:: 3299:: 3272:. 3250:: 3242:: 3236:5 3215:. 3191:: 3185:9 3164:. 3140:: 3113:. 3089:: 3057:. 3053:: 3030:. 3008:: 2978:. 2972:: 2966:7 2945:. 2931:: 2904:. 2880:: 2872:: 2866:7 2845:. 2823:: 2796:. 2774:: 2747:. 2725:: 2695:. 2673:: 2646:. 2624:: 2597:. 2573:: 2565:: 2538:. 2516:: 2489:. 2465:: 2438:. 2414:: 2397:n 2381:. 2361:: 2338:. 2314:: 2306:: 2279:. 2257:: 2230:. 2216:: 2189:. 2167:: 2140:. 2128:: 2105:. 2091:: 2064:. 2040:: 2032:: 2005:. 1983:: 1956:. 1934:: 1907:. 1887:: 1864:. 1842:: 1836:8 1814:. 1792:: 1784:: 1778:2 1757:. 1737:: 1714:. 1690:: 1682:: 1655:. 1651:: 1628:. 1606:: 1579:. 1557:: 1530:. 1508:: 1481:. 1459:: 1432:. 1420:: 1397:. 1385:: 1361:. 1357:: 1327:. 1305:: 1271:. 1251:: 1243:: 1215:. 1195:: 1187:: 1161:. 1139:: 1112:. 1090:: 1063:. 1039:: 1031:: 1025:6 899:2 897:C 895:4 891:2 889:C 887:4 883:2 881:C 879:4 875:2 873:C 871:4 863:2 861:C 859:4 747:G 743:N 739:G 735:N 731:G 727:N 138:(

Index


secondary structures
guanine
Hoogsteen
guanine tetrad
cation
potassium
DNA
RNA
LNA
PNA
intramolecular
bimolecular
parallel
antiparallel
guanine
DNA
telomeric
Aaron Klug

PDB
2HY9
meiosis
genome
chromatin
histone
thermodynamics
molecular crowding
Hoogsteen base pair
chromosome

Text is available under the Creative Commons Attribution-ShareAlike License. Additional terms may apply.

↑